Back to Details

epidemiologist-analyst

Compare original and translation side by side

🇺🇸

Original

English
🇨🇳

Translation

Chinese

Epidemiologist Analyst Skill

流行病分析师技能

Purpose

目的

Analyze health events and disease patterns through the disciplinary lens of epidemiology, applying established frameworks (disease surveillance, outbreak investigation, causal inference), multiple methodological approaches (cohort studies, case-control studies, mathematical modeling), and evidence-based practices to understand disease distribution, determinants, and control strategies that protect population health.
从流行病学学科视角分析健康事件与疾病模式，应用成熟框架（疾病监测、暴发调查、因果推断）、多种方法学路径（cohort studies、case-control studies、数学建模）及循证实践，以理解疾病分布、决定因素及保护人群健康的控制策略。

When to Use This Skill

技能适用场景

  • Disease Outbreak Investigation: Investigate foodborne illness, infectious disease clusters, unusual disease patterns
  • Health Policy Evaluation: Assess vaccination programs, screening initiatives, public health interventions
  • Risk Factor Analysis: Identify causes of chronic disease, environmental exposures, behavioral determinants
  • Surveillance System Design: Develop disease monitoring, early warning systems, syndromic surveillance
  • Intervention Planning: Design prevention strategies, evaluate control measures, optimize resource allocation
  • Public Health Emergency Response: Assess pandemic threats, coordinate containment strategies, model disease spread
  • Health Equity Assessment: Analyze disparities in disease burden, access to care, health outcomes across populations
  • 疾病暴发调查：调查食源性疾病、传染病聚集性病例、异常疾病模式
  • 卫生政策评估：评估疫苗接种项目、筛查举措、公共卫生干预措施
  • 风险因素分析：识别慢性病病因、环境暴露、行为决定因素
  • 监测系统设计：开发疾病监测、早期预警系统、症状监测
  • 干预规划：设计预防策略、评估控制措施、优化资源分配
  • 公共卫生应急响应：评估大流行威胁、协调防控策略、建模疾病传播
  • 健康公平性评估：分析不同人群的疾病负担差异、医疗可及性、健康结局差异

Core Philosophy: Epidemiological Thinking

核心理念：流行病学思维

Epidemiological analysis rests on several fundamental principles:
Population Perspective: Focus on groups rather than individuals. Disease patterns reveal underlying causes that individual cases cannot show.
Distribution and Determinants: Epidemiology studies both who gets diseases (distribution) and why they get them (determinants). Both dimensions are essential.
Causal Inference: Establishing causation requires rigorous criteria beyond simple association. Bradford Hill criteria guide assessment of causal relationships.
Prevention Focus: The ultimate goal is prevention. Understanding disease etiology enables interventions that prevent occurrence or reduce severity.
Quantitative Precision: Rates, risks, and ratios provide precise measures of disease occurrence and association strength. Numbers reveal patterns invisible to qualitative observation.
Time and Place Matter: Disease patterns vary by when and where they occur. Temporal and spatial analysis reveals transmission dynamics and risk factors.
Evidence-Based Action: Public health decisions must be grounded in rigorous data collection, analysis, and interpretation. Epidemiology provides the evidence base for action.
Interdisciplinary Integration: Epidemiology draws on biostatistics, clinical medicine, social sciences, and laboratory sciences to understand disease comprehensively.
流行病学分析基于若干基本原则：
人群视角：聚焦群体而非个体。疾病模式揭示了个体病例无法体现的潜在病因。
分布与决定因素：流行病学既研究谁会患病（分布），也研究为何患病（决定因素）。这两个维度至关重要。
因果推断：确立因果关系需要严格的标准，而非简单的关联。Bradford Hill criteria指导因果关系的评估。
预防导向：最终目标是预防。理解疾病病因有助于制定预防发病或降低严重程度的干预措施。
定量精准性：率、风险和比值为疾病发生及关联强度提供精准度量。数据揭示了定性观察无法发现的模式。
时间与地点的重要性：疾病模式随时间和地点而异。时空分析揭示传播动力学与风险因素。
循证行动：公共卫生决策必须基于严谨的数据收集、分析与解读。流行病学为行动提供证据基础。
跨学科整合：流行病学借鉴生物统计学、临床医学、社会科学和实验室科学，以全面理解疾病。

Theoretical Foundations (Expandable)

理论基础（可扩展）

Foundation 1: Germ Theory and Infectious Disease Epidemiology

基础1：微生物理论与传染病流行病学

Core Principles:
  • Specific microorganisms cause specific diseases
  • Transmission requires chain of infection: agent, reservoir, portal of exit, mode of transmission, portal of entry, susceptible host
  • Breaking any link in the chain prevents transmission
  • Exposure precedes disease (temporality)
  • Dose-response relationships exist between exposure and disease
Key Insights:
  • Understanding transmission modes enables targeted interventions
  • Asymptomatic carriers can propagate outbreaks
  • Herd immunity protects populations when sufficient proportion is immune
  • Emerging and re-emerging infections require constant vigilance
  • Antimicrobial resistance evolves under selection pressure
Founding Thinkers:
  • John Snow (1813-1858): Cholera investigation, removed Broad Street pump handle
  • Louis Pasteur (1822-1895): Germ theory, vaccination
  • Robert Koch (1843-1910): Koch's postulates for proving causation
When to Apply:
  • Investigating infectious disease outbreaks
  • Designing infection control measures
  • Evaluating vaccination strategies
  • Modeling epidemic spread
Sources:
核心原则：
  • 特定微生物引发特定疾病
  • 传播需要感染链：病原体、储存宿主、排出途径、传播方式、侵入途径、易感宿主
  • 打破感染链任一环节即可阻止传播
  • 暴露先于发病（时序性）
  • 暴露与疾病之间存在剂量-反应关系
关键洞见：
  • 理解传播方式有助于制定靶向干预措施
  • 无症状携带者可引发暴发
  • 当足够比例人群获得免疫时，群体免疫可保护人群
  • 新发和再发感染需要持续监测
  • 抗菌药物耐药性在选择压力下演化
奠基者：
  • John Snow（1813-1858）：霍乱调查，移除宽街水泵手柄
  • Louis Pasteur（1822-1895）：微生物理论，疫苗接种
  • Robert Koch（1843-1910）：科赫法则，用于证明因果关系
适用场景：
  • 调查传染病暴发
  • 设计感染控制措施
  • 评估疫苗接种策略
  • 建模流行病传播
资料来源：

Foundation 2: Chronic Disease Epidemiology

基础2：慢性病流行病学

Core Principles:
  • Chronic diseases have multiple contributing causes (web of causation)
  • Long latency periods between exposure and disease
  • Risk factors operate probabilistically, not deterministically
  • Behavioral, environmental, and genetic factors interact
  • Prevention possible at primary, secondary, and tertiary levels
Key Insights:
  • Most chronic diseases are preventable through lifestyle modification
  • Social determinants profoundly affect chronic disease risk
  • Early detection through screening reduces mortality
  • Small population shifts in risk factors yield large public health gains
  • Chronic disease burden is increasing globally with demographic transition
Key Thinkers:
  • Richard Doll & Austin Bradford Hill: Smoking and lung cancer studies
  • Framingham Heart Study researchers: Cardiovascular risk factors
  • Geoffrey Rose: Prevention paradox, population strategy
When to Apply:
  • Analyzing cardiovascular disease, cancer, diabetes patterns
  • Evaluating screening programs
  • Assessing behavioral risk factors
  • Designing prevention interventions
Sources:
核心原则：
  • 慢性病具有多重致病因素（病因网）
  • 暴露与发病之间存在较长潜伏期
  • 风险因素为概率性作用，而非确定性
  • 行为、环境和遗传因素相互作用
  • 可在一级、二级和三级预防层面实施干预
关键洞见：
  • 大多数慢性病可通过生活方式改变预防
  • 社会决定因素深刻影响慢性病风险
  • 通过筛查早期发现可降低死亡率
  • 人群风险因素的微小变化可带来巨大的公共卫生收益
  • 随着人口结构转型，慢性病负担在全球范围内不断增加
关键学者：
  • Richard Doll & Austin Bradford Hill：吸烟与肺癌研究
  • Framingham Heart Study研究者：心血管疾病风险因素
  • Geoffrey Rose：预防悖论、人群策略
适用场景：
  • 分析心血管疾病、癌症、糖尿病模式
  • 评估筛查项目
  • 评估行为风险因素
  • 设计预防干预措施
资料来源：

Foundation 3: Causal Inference and Bradford Hill Criteria

基础3：因果推断与Bradford Hill criteria

Core Principles:
  • Association does not prove causation
  • Multiple criteria strengthen causal inference: strength, consistency, specificity, temporality, biological gradient, plausibility, coherence, experiment, analogy
  • Confounding must be addressed through study design or analysis
  • Bias can distort observed associations
  • Natural experiments and quasi-experimental designs enable causal inference when randomization is infeasible
Key Insights:
  • Randomized controlled trials provide strongest causal evidence but are often impossible or unethical
  • Observational studies with careful design and analysis can support causal inference
  • Replication across populations and methods strengthens causal claims
  • Biological mechanisms provide supporting evidence
  • Effect modification reveals subgroups with different causal effects
Founding Thinker: Austin Bradford Hill (1897-1991)
  • Work: "The Environment and Disease: Association or Causation?" (1965)
  • Contributions: Established criteria for causal inference, pioneered randomized trials
When to Apply:
  • Evaluating whether observed associations are causal
  • Designing observational studies to minimize confounding
  • Assessing evidence for public health interventions
  • Distinguishing causation from correlation in complex data
Sources:
核心原则：
  • 关联不代表因果
  • 多重标准可强化因果推断：强度、一致性、特异性、时序性、生物梯度、合理性、连贯性、实验、类比
  • 必须通过研究设计或分析解决混杂问题
  • 偏倚可扭曲观察到的关联
  • 自然实验和准实验设计可在无法随机化的情况下实现因果推断
关键洞见：
  • 随机对照试验提供最强的因果证据，但往往不可行或不道德
  • 设计严谨的观察性研究可支持因果推断
  • 跨人群和方法的重复研究可强化因果主张
  • biological机制提供支持性证据
  • 效应修饰揭示具有不同因果效应的亚组
奠基学者：Austin Bradford Hill（1897-1991）
  • 著作：《环境与疾病：关联还是因果？》（1965）
  • 贡献：确立因果推断标准，开创随机试验
适用场景：
  • 评估观察到的关联是否为因果关系
  • 设计观察性研究以最小化混杂
  • 评估公共卫生干预措施的证据
  • 在复杂数据中区分因果与相关
资料来源：

Foundation 4: Disease Surveillance Systems

基础4：疾病监测系统

Core Principles:
  • Continuous systematic collection, analysis, and interpretation of health data
  • Early detection of outbreaks and emerging threats
  • Monitoring disease trends and evaluating interventions
  • Timeliness vs. completeness trade-offs
  • Integration of multiple data sources enhances sensitivity and specificity
Key Insights:
  • Surveillance is not research but ongoing public health practice
  • Syndromic surveillance detects outbreaks before laboratory confirmation
  • Electronic health records enable real-time surveillance
  • Wastewater-based epidemiology provides population-level disease signals
  • One Health approach integrates human, animal, and environmental surveillance
Modern Developments (2024-2025):
  • AI integration with mechanistic epidemiological models for disease forecasting
  • Wastewater-based epidemiology (WBE) coupled with machine learning for predictive health decisions
  • Evolution toward systems integration with multi-source data and improved early warning accuracy
When to Apply:
  • Designing disease monitoring systems
  • Detecting disease outbreaks early
  • Evaluating public health program effectiveness
  • Tracking health disparities
Sources:
核心原则：
  • 持续、系统地收集、分析和解读健康数据
  • 早期发现暴发和新发威胁
  • 监测疾病趋势并评估干预措施
  • 及时性与完整性的权衡
  • 整合多数据源可提升敏感性和特异性
关键洞见：
  • 监测是持续的公共卫生实践，而非研究
  • 症状监测可在实验室确诊前发现暴发
  • 电子健康记录支持实时监测
  • 基于污水的流行病学提供人群层面的疾病信号
  • One Health方法整合人类、动物和环境监测
现代发展（2024-2025）：
  • AI与机制性流行病学模型整合用于疾病预测
  • 基于污水的流行病学（WBE）结合机器学习用于预测性健康决策
  • 向多源数据整合和早期预警准确性提升的系统演进
适用场景：
  • 设计疾病监测系统
  • 早期发现疾病暴发
  • 评估公共卫生项目的有效性
  • 追踪健康差异
资料来源：

Foundation 5: Mathematical Modeling of Disease Spread

基础5：疾病传播数学建模

Core Principles:
  • Compartmental models (SIR, SEIR) describe population transitions between disease states
  • Basic reproduction number (R₀) determines epidemic potential
  • Transmission rate, contact patterns, and recovery rate govern dynamics
  • Interventions reduce R₀ below 1 to control epidemics
  • Uncertainty quantification essential for model credibility
Key Insights:
  • Small changes in R₀ have large effects on epidemic size
  • Timing of interventions critically affects outcomes
  • Models inform scenario planning, not precise prediction
  • Heterogeneity in contact patterns and susceptibility affects spread
  • Data-driven models improve forecasting accuracy
Key Concepts:
  • R₀ (Basic Reproduction Number): Average number of secondary infections from one infected individual in fully susceptible population
  • Epidemic Threshold: R₀ > 1 causes epidemic; R₀ < 1 causes decline
  • Herd Immunity Threshold: Proportion immune needed to prevent sustained transmission = 1 - 1/R₀
When to Apply:
  • Forecasting epidemic trajectories
  • Evaluating intervention strategies
  • Estimating vaccination coverage needs
  • Informing resource allocation during outbreaks
Sources:
核心原则：
  • compartmental models（SIR、SEIR）描述人群在疾病状态间的转换
  • 基本再生数（R₀）决定流行潜力
  • 传播率、接触模式和恢复率决定动力学
  • 干预措施将R₀降至1以下即可控制流行
  • 不确定性量化对模型可信度至关重要
关键洞见：
  • R₀的微小变化对流行规模影响巨大
  • 干预时机对结果至关重要
  • 模型为场景规划提供信息，而非精确预测
  • 接触模式和易感性的异质性影响传播
  • 数据驱动模型提升预测准确性
关键概念：
  • R₀（Basic Reproduction Number）：在完全易感人群中，一名感染者平均引发的二代病例数
  • 流行阈值：R₀ > 1引发流行；R₀ < 1导致疫情消退
  • 群体免疫阈值：阻止持续传播所需的免疫人群比例 = 1 - 1/R₀
适用场景：
  • 预测流行轨迹
  • 评估干预策略
  • 估算疫苗接种覆盖率需求
  • 在暴发期间指导资源分配
资料来源：

Core Analytical Frameworks (Expandable)

核心分析框架（可扩展）

Framework 1: Outbreak Investigation

框架1：暴发调查

Definition: "Systematic process of detecting, investigating, and controlling disease outbreaks to protect public health"
The 10-Step CDC Approach:
  1. Prepare for field work - Assemble team, gather supplies, review background
  2. Establish the existence of an outbreak - Compare current incidence to baseline
  3. Verify the diagnosis - Confirm through clinical and laboratory methods
  4. Define and identify cases - Create case definition, conduct case finding
  5. Describe and orient data - Analyze by person, place, and time (epidemiologic triad)
  6. Develop hypotheses - Generate potential sources and transmission modes
  7. Evaluate hypotheses - Conduct analytic studies (cohort or case-control)
  8. Refine hypotheses and execute additional studies - Address remaining questions
  9. Implement control and prevention measures - Act on findings to stop outbreak
  10. Communicate findings - Report to stakeholders and public health community
Key Components:
  • Epidemic Curve: Graphical representation of cases over time revealing outbreak pattern
  • Case Definition: Standardized criteria for identifying cases (clinical, laboratory, epidemiologic criteria)
  • Attack Rate: Proportion of exposed population that develops disease
  • Spot Map: Geographic distribution of cases revealing spatial clustering
Applications:
  • Foodborne illness outbreaks
  • Healthcare-associated infections
  • Infectious disease clusters
  • Environmental exposures
  • Vaccine-preventable disease resurgence
Example Analysis:
  • Restaurant outbreak: Epidemic curve shows point-source pattern, case-control study identifies implicated food, environmental sampling confirms contamination, restaurant closure prevents additional cases
Sources:
定义："系统地检测、调查和控制疾病暴发以保护公共卫生的过程"
CDC的10步方法：
  1. 准备现场工作 - 组建团队、准备物资、回顾背景信息
  2. 确认暴发存在 - 将当前发病率与基线比较
  3. 验证诊断 - 通过临床和实验室方法确认
  4. 定义并识别病例 - 制定病例定义、开展病例搜索
  5. 描述并梳理数据 - 按人群、地点和时间（流行病学三角）分析
  6. 提出假设 - 生成潜在来源和传播方式
  7. 评估假设 - 开展分析性研究（队列或病例对照）
  8. 细化假设并开展额外研究 - 解决剩余问题
  9. 实施控制和预防措施 - 根据发现采取行动以终止暴发
  10. 沟通发现 - 向利益相关方和公共卫生界报告
关键组件：
  • 流行曲线：病例随时间变化的图形化呈现，揭示暴发模式
  • 病例定义：识别病例的标准化标准（临床、实验室、流行病学标准）
  • 罹患率：暴露人群中发病的比例
  • 斑点图：病例的地理分布，揭示空间聚集性
应用：
  • 食源性疾病暴发
  • 医疗机构相关性感染
  • 传染病聚集性病例
  • 环境暴露
  • 疫苗可预防疾病的复燃
分析示例：
  • 餐厅暴发：流行曲线显示点源模式，病例对照研究识别致病食物，环境采样确认污染，关闭餐厅阻止新增病例
资料来源：

Framework 2: Study Design - Cohort and Case-Control Studies

框架2：研究设计 - 队列研究与病例对照研究

Definition: "Analytic epidemiology methods comparing disease occurrence between exposed and unexposed groups to quantify associations"
Cohort Study Design:
  • Approach: Identify exposed and unexposed groups, follow forward in time, compare disease incidence
  • Measures: Relative risk (RR), attributable risk, incidence rates
  • Strengths: Direct measure of incidence, can assess multiple outcomes, temporality clear
  • Best for: Outbreaks in defined populations, common exposures, short latency diseases
Case-Control Study Design:
  • Approach: Identify cases and controls, look backward to assess past exposures, compare exposure odds
  • Measures: Odds ratio (OR approximates RR when disease is rare)
  • Strengths: Efficient for rare diseases, rapid results, fewer subjects needed
  • Best for: Large populations, rare diseases, long latency, multiple exposures
Study Selection Criteria:
  • Population definition and accessibility
  • Disease frequency and latency period
  • Available resources and timeline
  • Feasibility of exposure assessment
Applications:
  • Outbreak investigations (cohort for defined populations like weddings, case-control for community outbreaks)
  • Chronic disease etiology research
  • Vaccine safety and effectiveness studies
  • Environmental exposure assessment
Example Analysis:
  • Hepatitis A outbreak: Case-control study identifies green onions as risk factor (OR = 5.2, 95% CI: 2.1-12.8), traceback investigation finds contaminated supply, recall initiated
Sources:
定义："比较暴露与非暴露人群疾病发生情况以量化关联的分析流行病学方法"
队列研究设计：
  • 方法：识别暴露与非暴露人群，随时间随访，比较疾病发病率
  • 指标：相对风险（RR）、归因风险、发病率
  • 优势：直接测量发病率，可评估多种结局，时序性明确
  • 最佳适用场景：定义人群中的暴发、常见暴露、短潜伏期疾病
病例对照研究设计：
  • 方法：识别病例与对照，回顾既往暴露情况，比较暴露比值
  • 指标：比值比（OR，当疾病罕见时近似RR）
  • 优势：对罕见病高效，结果快速，所需样本量少
  • 最佳适用场景：大人群、罕见病、长潜伏期、多种暴露
研究选择标准：
  • 人群定义与可及性
  • 疾病频率与潜伏期
  • 可用资源与时间线
  • 暴露评估的可行性
应用：
  • 暴发调查（队列研究适用于婚礼等定义人群，病例对照研究适用于社区暴发）
  • 慢性病病因研究
  • 疫苗安全性与有效性研究
  • 环境暴露评估
分析示例：
  • 甲型肝炎暴发：病例对照研究识别洋葱为风险因素（OR = 5.2，95% CI: 2.1-12.8），溯源调查发现污染供应源，启动召回
资料来源：

Framework 3: Measures of Disease Frequency and Association

框架3：疾病频率与关联度量

Definition: "Quantitative metrics describing disease occurrence in populations and strength of relationships between exposures and outcomes"
Measures of Disease Frequency:
  • Incidence: Number of new cases per population per time (rate of disease development)
  • Prevalence: Proportion of population with disease at specific time (disease burden)
  • Attack Rate: Incidence in outbreak setting (proportion of exposed who develop disease)
  • Mortality Rate: Deaths per population per time
  • Case Fatality Rate: Proportion of cases who die
Measures of Association:
  • Relative Risk (RR): Ratio of incidence in exposed vs. unexposed (RR > 1 suggests increased risk)
  • Odds Ratio (OR): Ratio of odds of exposure in cases vs. controls
  • Attributable Risk: Absolute difference in incidence between exposed and unexposed
  • Population Attributable Risk: Incidence in total population attributable to exposure
  • Number Needed to Treat (NNT): Number needed to treat to prevent one adverse outcome
Key Concepts:
  • Rates have time component; proportions do not
  • Confidence intervals quantify statistical uncertainty
  • P-values test null hypothesis but don't measure effect size
  • Clinical significance differs from statistical significance
Applications:
  • Comparing disease burden across populations
  • Quantifying strength of risk factor associations
  • Evaluating intervention effectiveness
  • Prioritizing public health interventions based on population impact
Example Analysis:
  • Smoking and lung cancer: RR = 20 means smokers have 20 times the risk of nonsmokers; attributable risk = 90% means 90% of lung cancer in smokers is due to smoking
Sources:
定义："描述人群疾病发生及暴露与结局关联强度的定量指标"
疾病频率度量：
  • 发病率：单位时间内人群中新发病例数（疾病发生率）
  • 患病率：特定时间点人群中患病的比例（疾病负担）
  • 罹患率：暴发场景中的发病率（暴露人群中发病的比例）
  • 死亡率：单位时间内人群中的死亡数
  • 病死率：病例中死亡的比例
关联度量：
  • 相对风险（RR）：暴露人群与非暴露人群发病率的比值（RR > 1提示风险增加）
  • 比值比（OR）：病例与对照的暴露比值比
  • 归因风险：暴露与非暴露人群发病率的绝对差异
  • 人群归因风险：总人群中可归因于暴露的发病率
  • 需治疗人数（NNT）：预防1例不良结局所需治疗的人数
关键概念：
  • 率包含时间成分；比例不包含
  • 置信区间量化统计不确定性
  • P值检验零假设，但不衡量效应大小
  • 临床意义与统计意义不同
应用：
  • 比较不同人群的疾病负担
  • 量化风险因素关联强度
  • 评估干预措施有效性
  • 根据人群影响优先级排序公共卫生干预措施
分析示例：
  • 吸烟与肺癌：RR = 20意味着吸烟者的肺癌风险是非吸烟者的20倍；归因风险 = 90%意味着吸烟者中90%的肺癌由吸烟导致
资料来源：

Framework 4: Screening and Diagnostic Test Evaluation

框架4：筛查与诊断试验评估

Definition: "Assessment of test performance in identifying disease, balancing sensitivity, specificity, and predictive values"
Key Performance Metrics:
  • Sensitivity: Proportion of true positives correctly identified (1 - false negative rate)
  • Specificity: Proportion of true negatives correctly identified (1 - false positive rate)
  • Positive Predictive Value (PPV): Probability disease present given positive test
  • Negative Predictive Value (NPV): Probability disease absent given negative test
  • ROC Curve: Plots sensitivity vs. (1-specificity) across test thresholds
Critical Insights:
  • PPV and NPV depend on disease prevalence (sensitivity and specificity do not)
  • No test is perfect; trade-offs exist between sensitivity and specificity
  • Screening tests should be highly sensitive (few false negatives)
  • Confirmatory tests should be highly specific (few false positives)
  • Serial testing increases specificity; parallel testing increases sensitivity
Wilson-Jungner Screening Criteria (WHO):
  1. Condition is important health problem
  2. Natural history is well understood
  3. Recognizable early stage exists
  4. Effective treatment available for early disease
  5. Suitable test exists
  6. Test acceptable to population
  7. Facilities for diagnosis and treatment available
  8. Policy on whom to treat
  9. Cost-effective
  10. Continuous case-finding process
Applications:
  • Evaluating COVID-19 rapid tests
  • Designing cancer screening programs
  • Assessing syndromic surveillance systems
  • Optimizing diagnostic algorithms
Example Analysis:
  • COVID-19 rapid antigen test: Sensitivity = 85%, Specificity = 99%, but PPV varies dramatically by prevalence (PPV = 46% at 1% prevalence, PPV = 98% at 50% prevalence)
Sources:
定义："评估试验识别疾病的性能，平衡敏感性、特异性和预测值"
关键性能指标：
  • 敏感性：正确识别的真阳性比例（1 - 假阴性率）
  • 特异性：正确识别的真阴性比例（1 - 假阳性率）
  • 阳性预测值（PPV）：试验阳性时患病的概率
  • 阴性预测值（NPV）：试验阴性时未患病的概率
  • ROC曲线：绘制不同试验阈值下的敏感性与（1-特异性）
关键洞见：
  • PPV和NPV取决于疾病患病率（敏感性和特异性不取决于患病率）
  • 没有完美的试验；敏感性与特异性之间存在权衡
  • 筛查试验应具有高敏感性（假阴性少）
  • 确认试验应具有高特异性（假阳性少）
  • 系列试验提升特异性；平行试验提升敏感性
Wilson-Jungner筛查标准（WHO）：
  1. 疾病是重要的健康问题
  2. 自然史明确
  3. 存在可识别的早期阶段
  4. 早期疾病有有效的治疗方法
  5. 存在合适的试验
  6. 试验为人群所接受
  7. 具备诊断和治疗设施
  8. 明确治疗对象的政策
  9. 具有成本效益
  10. 持续的病例搜索过程
应用：
  • 评估COVID-19快速检测
  • 设计癌症筛查项目
  • 评估症状监测系统
  • 优化诊断算法
分析示例：
  • COVID-19快速抗原检测：敏感性 = 85%，特异性 = 99%，但PPV随患病率变化巨大（患病率1%时PPV = 46%，患病率50%时PPV = 98%）
资料来源：

Framework 5: Epidemic Curves and Disease Pattern Recognition

框架5：流行曲线与疾病模式识别

Definition: "Graphical representation of cases by time of onset revealing outbreak source, transmission pattern, and trajectory"
Epidemic Curve Types:
  • Point-Source: Single exposure, sharp peak, cases within one incubation period
  • Continuous Common Source: Ongoing exposure, plateau pattern
  • Propagated: Person-to-person spread, successive peaks spaced by incubation period
  • Mixed: Combination of patterns (e.g., initial point source followed by secondary transmission)
Key Features to Analyze:
  • Shape: Reveals transmission mode
  • Peak timing: Suggests exposure time (working backward by incubation period)
  • Duration: Indicates length of exposure or transmission chains
  • Outliers: May represent index case or unrelated cases
  • Magnitude: Total cases and attack rate
Additional Descriptive Tools:
  • Person: Age, sex, occupation, risk factors
  • Place: Geographic distribution (spot maps, cluster detection)
  • Time: Trends, seasonality, periodicity
Applications:
  • Determining outbreak source and timing
  • Distinguishing foodborne from person-to-person transmission
  • Predicting outbreak trajectory
  • Evaluating control measure effectiveness (curve flattening)
Example Analysis:
  • Food poisoning at picnic: Sharp peak 6-12 hours post-event, all cases within 24 hours → suggests point-source, short incubation toxin like Staph aureus
  • COVID-19: Propagated curves with peaks every 5-7 days indicating serial intervals
Sources:
定义："按发病时间呈现病例的图形化方式，揭示暴发来源、传播模式和轨迹"
流行曲线类型：
  • 点源：单次暴露，峰值尖锐，病例集中在一个潜伏期内
  • 持续共同来源：持续暴露，平台模式
  • 传播性：人传人传播，连续峰值间隔一个潜伏期
  • 混合：模式组合（如初始点源后出现二代传播）
需分析的关键特征：
  • 形状：揭示传播方式
  • 峰值时间：提示暴露时间（按潜伏期倒推）
  • 持续时间：提示暴露长度或传播链持续时间
  • 异常值：可能为指示病例或无关病例
  • 规模：总病例数和罹患率
其他描述工具：
  • 人群：年龄、性别、职业、风险因素
  • 地点：地理分布（斑点图、聚集性检测）
  • 时间：趋势、季节性、周期性
应用：
  • 确定暴发来源和时间
  • 区分食源性与人际传播
  • 预测暴发轨迹
  • 评估控制措施有效性（曲线扁平化）
分析示例：
  • 野餐食物中毒：事件后6-12小时出现尖锐峰值，所有病例在24小时内 → 提示点源、短潜伏期毒素（如金黄色葡萄球菌）
  • COVID-19：传播性曲线每5-7天出现一次峰值，提示系列间隔
资料来源：

Methodological Approaches (Expandable)

方法学路径（可扩展）

Method 1: Disease Surveillance

方法1：疾病监测

Purpose: "Ongoing systematic collection, analysis, and interpretation of health data for planning, implementing, and evaluating public health practice"
Approach:
  1. Define surveillance objectives and case definitions
  2. Establish data collection mechanisms (passive vs. active)
  3. Implement data management and analysis systems
  4. Disseminate findings to stakeholders
  5. Evaluate surveillance system attributes (sensitivity, timeliness, acceptability, etc.)
Types of Surveillance:
  • Passive: Healthcare providers report cases to health department
  • Active: Health department proactively contacts providers
  • Syndromic: Monitors symptoms before diagnosis (e.g., emergency department chief complaints)
  • Sentinel: Selected reporting sites provide representative data
  • Wastewater-Based: Monitors pathogens in sewage for population-level signals
Strengths:
  • Detects outbreaks early
  • Monitors disease trends over time
  • Evaluates intervention impact
  • Identifies emerging health threats
Applications:
  • Influenza surveillance networks
  • COVID-19 case reporting
  • Foodborne disease surveillance (FoodNet, PulseNet)
  • Antimicrobial resistance monitoring
  • Chronic disease tracking (BRFSS)
Sources:
目的："持续、系统地收集、分析和解读健康数据，以规划、实施和评估公共卫生实践"
方法：
  1. 定义监测目标和病例定义
  2. 建立数据收集机制（被动 vs 主动）
  3. 实施数据管理和分析系统
  4. 向利益相关方传播发现
  5. 评估监测系统属性（敏感性、及时性、可接受性等）
监测类型：
  • 被动监测：医疗服务提供者向卫生部门报告病例
  • 主动监测：卫生部门主动联系提供者
  • 症状监测：在确诊前监测症状（如急诊科主诉）
  • 哨点监测：选定的报告站点提供代表性数据
  • 基于污水的监测：监测污水中的病原体以获取人群层面信号
优势：
  • 早期发现暴发
  • 长期监测疾病趋势
  • 评估干预措施影响
  • 识别新发健康威胁
应用：
  • 流感监测网络
  • COVID-19病例报告
  • 食源性疾病监测（FoodNet、PulseNet）
  • 抗菌药物耐药性监测
  • 慢性病追踪（BRFSS）
资料来源：

Method 2: Outbreak Investigation

方法2：暴发调查

Purpose: "Identify source, mode of transmission, and control measures to stop ongoing disease transmission"
Approach:
  1. Confirm outbreak exists (compare to baseline)
  2. Verify diagnosis through clinical/lab assessment
  3. Define cases using standardized criteria
  4. Find cases through active surveillance
  5. Describe cases by person, place, time
  6. Generate hypotheses about source/transmission
  7. Test hypotheses using analytic studies
  8. Implement control measures
  9. Communicate findings
Key Steps Detail:
  • Case finding: Active search beyond passive reporting
  • Epidemic curve construction: Reveal temporal pattern
  • Hypothesis generation: Environmental assessment, interviews, literature review
  • Analytic studies: Cohort or case-control study to identify risk factors
  • Environmental investigation: Inspect sites, collect samples
Strengths:
  • Rapid identification and control of source
  • Prevents additional cases
  • Generates evidence for future prevention
  • Builds public health capacity
Applications:
  • Foodborne illness investigations
  • Healthcare-associated infection outbreaks
  • Legionnaires' disease cluster investigations
  • Vaccine-preventable disease outbreaks
Sources:
目的："识别来源、传播方式和控制措施以终止疾病持续传播"
方法：
  1. 确认暴发存在（与基线比较）
  2. 通过临床/实验室评估验证诊断
  3. 使用标准化标准定义病例
  4. 通过主动监测搜索病例
  5. 按人群、地点、时间描述病例
  6. 生成关于来源/传播的假设
  7. 使用分析性研究检验假设
  8. 实施控制措施
  9. 沟通发现
关键步骤细节：
  • 病例搜索：在被动报告之外主动搜索
  • 流行曲线构建：揭示时间模式
  • 假设生成：环境评估、访谈、文献回顾
  • 分析性研究：队列或病例对照研究识别风险因素
  • 环境调查：检查场所、采集样本
优势：
  • 快速识别并控制来源
  • 预防新增病例
  • 为未来预防提供证据
  • 提升公共卫生能力
应用：
  • 食源性疾病调查
  • 医疗机构相关性感染暴发
  • 军团病聚集性病例调查
  • 疫苗可预防疾病暴发
资料来源：

Method 3: Cohort and Case-Control Studies

方法3：队列研究与病例对照研究

Purpose: "Quantify associations between exposures and health outcomes to establish risk factors and causal relationships"
Cohort Study Approach:
  1. Define study population and exposure of interest
  2. Classify individuals by exposure status
  3. Follow cohort over time
  4. Identify disease occurrence
  5. Calculate and compare incidence rates between exposed and unexposed
  6. Assess confounding and effect modification
Case-Control Study Approach:
  1. Define cases (people with disease) and controls (people without disease)
  2. Ensure controls representative of population that gave rise to cases
  3. Assess past exposures through interviews, records, biomarkers
  4. Calculate odds ratio comparing exposure odds in cases vs. controls
  5. Adjust for confounders through matching or statistical methods
Strengths:
  • Cohort: Direct incidence measures, multiple outcomes, temporality clear, no recall bias
  • Case-Control: Efficient for rare diseases, quick results, multiple exposures, less expensive
Limitations:
  • Cohort: Expensive, time-consuming, inefficient for rare diseases, loss to follow-up
  • Case-Control: Cannot calculate incidence, recall bias, selection bias, temporality unclear for some exposures
Applications:
  • Cohort: Framingham Heart Study, Nurses' Health Study, COVID-19 vaccine effectiveness
  • Case-Control: Smoking and lung cancer, Reye syndrome and aspirin, bacterial meningitis outbreak
Sources:
目的："量化暴露与健康结局的关联以确立风险因素和因果关系"
队列研究方法：
  1. 定义研究人群和关注的暴露因素
  2. 按暴露状态分类个体
  3. 随时间随访队列
  4. 识别疾病发生情况
  5. 计算并比较暴露与非暴露人群的发病率
  6. 评估混杂和效应修饰
病例对照研究方法：
  1. 定义病例（患病者）和对照（未患病者）
  2. 确保对照代表产生病例的人群
  3. 通过访谈、记录、生物标志物评估既往暴露
  4. 计算病例与对照的暴露比值比
  5. 通过匹配或统计方法调整混杂因素
优势：
  • 队列研究：直接测量发病率，可评估多种结局，时序性明确，无回忆偏倚
  • 病例对照研究：对罕见病高效，结果快速，可评估多种暴露，成本较低
局限性：
  • 队列研究：成本高、耗时长、对罕见病低效、失访问题
  • 病例对照研究：无法计算发病率、存在回忆偏倚、选择偏倚、部分暴露的时序性不明确
应用：
  • 队列研究：Framingham心脏研究、护士健康研究、COVID-19疫苗有效性研究
  • 病例对照研究：吸烟与肺癌、Reye综合征与阿司匹林、细菌性脑膜炎暴发
资料来源：

Method 4: Mathematical and Statistical Modeling

方法4：数学与统计建模

Purpose: "Use mathematical representations of disease transmission to forecast epidemics, evaluate interventions, and understand dynamics"
Approach:
  1. Select model structure (compartmental, agent-based, statistical)
  2. Parameterize model using literature, data, or calibration
  3. Validate model against observed data
  4. Conduct sensitivity analysis to assess uncertainty
  5. Simulate scenarios (baseline, interventions, worst-case)
  6. Communicate results with uncertainty quantification
Model Types:
  • Compartmental Models: SIR, SEIR, SEIRS dividing population into disease states
  • Agent-Based Models: Simulate individuals with heterogeneous characteristics and contact networks
  • Statistical Models: Regression, time series, machine learning for forecasting
  • Hybrid Models: Combine mechanistic and data-driven approaches (AI integration)
Key Parameters:
  • R₀ (basic reproduction number)
  • Generation time / serial interval
  • Infectious period
  • Contact rates
  • Intervention effectiveness
Strengths:
  • Forecasts epidemic trajectory
  • Evaluates interventions before implementation
  • Identifies key drivers of transmission
  • Informs resource allocation
  • Integrates diverse data sources
Limitations:
  • Models simplify complex reality
  • Uncertainty in parameters and structure
  • Quality depends on input data
  • Should inform decisions, not dictate them
Applications:
  • COVID-19 pandemic projections
  • Influenza vaccination strategy optimization
  • Ebola outbreak response planning
  • Vector-borne disease control evaluation
Sources:
目的："使用疾病传播的数学表征预测流行、评估干预措施并理解动力学"
方法：
  1. 选择模型结构（compartmental、agent-based、统计模型）
  2. 使用文献、数据或校准参数化模型
  3. 验证模型与观察数据的一致性
  4. 开展敏感性分析以评估不确定性
  5. 模拟场景（基线、干预、最坏情况）
  6. 量化不确定性并传播结果
模型类型：
  • Compartmental Models：SIR、SEIR、SEIRS将人群分为不同疾病状态
  • Agent-Based Models：模拟具有异质性特征和接触网络的个体
  • 统计模型：回归、时间序列、机器学习用于预测
  • 混合模型：结合机制性和数据驱动方法（AI整合）
关键参数：
  • R₀（基本再生数）
  • 代时 / 系列间隔
  • 传染期
  • 接触率
  • 干预措施有效性
优势：
  • 预测流行轨迹
  • 在实施前评估干预措施
  • 识别传播的关键驱动因素
  • 指导资源分配
  • 整合多源数据
局限性：
  • 模型简化复杂现实
  • 参数和结构存在不确定性
  • 质量依赖输入数据
  • 应为决策提供信息，而非主导决策
应用：
  • COVID-19大流行预测
  • 流感疫苗接种策略优化
  • 埃博拉暴发响应规划
  • 媒介传播疾病控制评估
资料来源：

Method 5: Screening and Prevention Programs

方法5：筛查与预防项目

Purpose: "Detect disease early to enable timely intervention and prevent disease occurrence through primary prevention"
Screening Program Approach:
  1. Identify target population and screening test
  2. Ensure test meets sensitivity/specificity requirements
  3. Establish diagnostic follow-up for positive screens
  4. Implement quality assurance and monitoring
  5. Evaluate program effectiveness and cost-effectiveness
Prevention Levels:
  • Primary Prevention: Prevent disease occurrence (vaccination, behavior change, environmental modification)
  • Secondary Prevention: Detect disease early when treatment most effective (screening)
  • Tertiary Prevention: Reduce complications and disability in those with disease (disease management)
Evaluation Metrics:
  • Coverage (proportion of target population screened)
  • Positive predictive value
  • Interval cancers (cases between screens)
  • Stage distribution at diagnosis
  • Mortality reduction
  • Cost per quality-adjusted life year (QALY)
Strengths:
  • Reduces disease burden through early detection
  • Prevents disease through risk factor modification
  • Cost-effective when well-designed
  • Population-level impact
Limitations:
  • Overdiagnosis risk (detecting indolent disease)
  • False positives cause anxiety and unnecessary procedures
  • Not all diseases suitable for screening
  • Requires ongoing resources and quality assurance
Applications:
  • Cancer screening (colorectal, breast, cervical)
  • Newborn screening for metabolic disorders
  • Hypertension and diabetes screening
  • HIV screening
  • Vaccination programs
Sources:
目的："早期发现疾病以实施及时干预，并通过一级预防阻止疾病发生"
筛查项目方法：
  1. 确定目标人群和筛查试验
  2. 确保试验满足敏感性/特异性要求
  3. 为阳性筛查结果建立诊断随访流程
  4. 实施质量保证和监测
  5. 评估项目有效性和成本效益
预防层级：
  • 一级预防：阻止疾病发生（疫苗接种、行为改变、环境改造）
  • 二级预防：在治疗最有效的阶段早期发现疾病（筛查）
  • 三级预防：减少患者的并发症和残疾（疾病管理）
评估指标：
  • 覆盖率（目标人群中接受筛查的比例）
  • 阳性预测值
  • 间隔癌（筛查间隔期间的病例）
  • 诊断时的分期分布
  • 死亡率降低
  • 每质量调整生命年（QALY）成本
优势：
  • 通过早期发现减少疾病负担
  • 通过风险因素 modification 预防疾病
  • 设计良好时具有成本效益
  • 人群层面影响
局限性：
  • 过度诊断风险（检测惰性疾病）
  • 假阳性导致焦虑和不必要的操作
  • 并非所有疾病都适合筛查
  • 需要持续资源和质量保证
应用：
  • 癌症筛查（结直肠癌、乳腺癌、宫颈癌）
  • 新生儿代谢疾病筛查
  • 高血压和糖尿病筛查
  • HIV筛查
  • 疫苗接种项目
资料来源：

Analysis Rubric

分析 rubric

What to Examine

需检查的内容

Disease Characteristics:
  • Clinical presentation and severity spectrum
  • Incubation period and infectious period
  • Modes of transmission
  • Case fatality rate and morbidity
Population Patterns:
  • Who is affected (age, sex, occupation, risk factors)
  • Geographic distribution and clustering
  • Temporal trends and seasonality
  • Attack rates in different groups
Transmission Dynamics:
  • Epidemic curve pattern (point-source, propagated, mixed)
  • Basic reproduction number (R₀) and effective R
  • Generation time and serial interval
  • Contact patterns and mixing
Risk Factors and Exposures:
  • Behavioral, environmental, occupational exposures
  • Underlying conditions and immunological status
  • Genetic susceptibility
  • Social determinants of health
Intervention Opportunities:
  • Primary prevention strategies
  • Early detection and screening potential
  • Treatment availability and effectiveness
  • Control measures feasibility and acceptability
Surveillance and Data Quality:
  • Case ascertainment methods and completeness
  • Laboratory confirmation availability
  • Timeliness of reporting
  • Data representativeness
疾病特征：
☐ 临床表型和严重程度谱清晰描述 ☐ 潜伏期和传染期明确 ☐ 传播方式有证据支持 ☐ 病例定义适当且标准化（临床、实验室、流行病学标准）
描述性流行病学：
☐ 按人群、地点和时间描述病例 ☐ 构建流行曲线以显示时间模式 ☐ 计算相关亚组的罹患率 ☐ 绘制地理分布（如相关） ☐ 调查异常值和不寻常模式
分析性流行病学：
☐ 选择适当的研究设计（队列、病例对照、生态学） ☐ 暴露评估全面且无偏倚 ☐ 计算关联度量（RR、OR等）并给出置信区间 ☐ 适当评估统计显著性 ☐ 评估并解决混杂问题（分层、多变量调整） ☐ 评估相关的效应修饰
因果推断：
☐ 应用Bradford Hill criteria评估因果关系 ☐ 确立时序性（暴露先于疾病） ☐ 考虑生物学合理性 ☐ 评估剂量-反应关系（如适用） ☐ 排除或解决替代解释（混杂、偏倚）
数据质量与有效性：
☐ 评估监测敏感性和完整性 ☐ 考虑选择偏倚并最小化 ☐ 评估信息偏倚（回忆、测量） ☐ 实验室方法适当且经过质量保证 ☐ 样本量满足统计效力
公共卫生响应：
☐ 识别并实施控制措施 ☐ 明确干预的目标人群 ☐ 确定所需资源 ☐ 明确如何衡量有效性 ☐ 考虑潜在的意外后果
健康公平性：
☐ 确定哪些人群承担不成比例的疾病负担 ☐ 确定预防和医疗服务的障碍 ☐ 确定干预措施如何解决差异 ☐ 监测是否纳入脆弱人群

Questions to Ask

需提出的问题

About the Disease Pattern:
  • Is this an outbreak or expected variation?
  • What is the source of infection or exposure?
  • How is disease transmitted?
  • Who is at highest risk?
  • Is the outbreak ongoing or resolved?
About Causation:
  • What is the strength of association (RR, OR)?
  • Is the association consistent across studies and populations?
  • Does exposure precede disease?
  • Is there a dose-response relationship?
  • Is the association biologically plausible?
  • Are there alternative explanations (confounding, bias)?
About Public Health Response:
  • What control measures are needed immediately?
  • What is the target population for intervention?
  • What resources are required?
  • How will effectiveness be measured?
  • What are potential unintended consequences?
About Health Equity:
  • Which populations bear disproportionate disease burden?
  • What are barriers to prevention and care?
  • How can interventions address disparities?
  • Are vulnerable populations included in surveillance?
关于疾病模式：
  • 这是暴发还是预期变异？
  • 感染或暴露的来源是什么？
  • 疾病如何传播？
  • 谁的风险最高？
  • 暴发是否仍在持续或已结束？
关于因果关系：
  • 关联强度如何（RR、OR）？
  • 关联在不同研究和人群中是否一致？
  • 暴露是否先于疾病？
  • 是否存在剂量-反应关系？
  • 关联是否具有生物学合理性？
  • 是否存在替代解释（混杂、偏倚）？
关于公共卫生响应：
  • 立即需要哪些控制措施？
  • 干预的目标人群是什么？
  • 需要哪些资源？
  • 如何衡量有效性？
  • 潜在的意外后果是什么？
关于健康公平性：
  • 哪些人群承担不成比例的疾病负担？
  • 预防和医疗服务的障碍是什么？
  • 干预措施如何解决差异？
  • 监测是否纳入脆弱人群？

Factors to Consider

需考虑的因素

Data Quality:
  • Surveillance sensitivity and specificity
  • Case definition appropriateness
  • Completeness of case finding
  • Representativeness of sample
Study Design Validity:
  • Selection bias (cases/controls not comparable)
  • Information bias (recall bias, measurement error)
  • Confounding (third variable distorts association)
  • Adequate statistical power
Biological Plausibility:
  • Known mechanisms of disease causation
  • Host susceptibility factors
  • Agent virulence and infectivity
  • Environmental conduciveness to transmission
Implementation Feasibility:
  • Resource availability (personnel, supplies, funding)
  • Infrastructure capacity (laboratory, healthcare, communication)
  • Political will and community acceptance
  • Sustainability of interventions
数据质量：
  • 监测敏感性和特异性
  • 病例定义的适当性
  • 病例搜索的完整性
  • 样本的代表性
研究设计有效性：
  • 选择偏倚（病例/对照不可比）
  • 信息偏倚（回忆偏倚、测量误差）
  • 混杂（第三变量扭曲关联）
  • 足够的统计效力
生物学合理性：
  • 已知的疾病致病机制
  • 宿主易感性因素
  • 病原体毒力和传染性
  • 环境对传播的适宜性
实施可行性：
  • 资源可用性（人员、物资、资金）
  • 基础设施能力（实验室、医疗、通信）
  • 政治意愿和社区接受度
  • 干预措施的可持续性

Historical Parallels

历史借鉴

Classic Investigations to Reference:
  • John Snow's Cholera Investigation (1854): Mapped cases, identified contaminated water pump, removed handle to stop outbreak
  • Legionnaires' Disease (1976): Identified new pathogen through persistence and collaboration
  • HIV/AIDS (1980s): Recognized new syndrome through surveillance, identified transmission routes
  • SARS (2003): Global coordination, rapid characterization, containment through isolation and quarantine
  • H1N1 Influenza Pandemic (2009): Real-time surveillance, rapid vaccine development, international coordination
Lessons from History:
  • Shoe-leather epidemiology remains essential despite technology advances
  • Rapid communication and transparency save lives
  • Preparedness systems detect and respond faster
  • Political support enables effective response
  • Global threats require global collaboration
可参考的经典调查：
  • John Snow的霍乱调查（1854）：绘制病例地图，识别受污染的水泵，移除手柄以终止暴发
  • 军团病（1976）：通过坚持和合作识别新病原体
  • HIV/AIDS（1980年代）：通过监测识别新综合征，确定传播途径
  • SARS（2003）：全球协作、快速表征、通过隔离和检疫控制
  • H1N1流感大流行（2009）：实时监测、快速疫苗开发、国际协作
历史教训：
  • 尽管技术进步，实地流行病学仍然至关重要
  • 快速沟通和透明可挽救生命
  • 准备系统可更快地检测和响应
  • 政治支持使有效响应成为可能
  • 全球威胁需要全球协作

Implications to Explore

需探索的影响

Public Health Action:
  • Immediate control measures (isolation, quarantine, recalls, closures)
  • Surveillance enhancement for case finding
  • Public communication and risk messaging
  • Healthcare system preparedness
Policy Considerations:
  • Resource allocation for prevention and control
  • Legal authorities for public health action (mandatory reporting, isolation powers)
  • Equity in intervention access
  • Balance between individual liberty and collective protection
Research Needs:
  • Pathogen characterization and virulence factors
  • Treatment and vaccine development
  • Risk factor identification through analytic studies
  • Intervention effectiveness evaluation
  • Long-term sequelae assessment
公共卫生行动：
  • 立即控制措施（隔离、检疫、召回、关闭）
  • 加强监测以开展病例搜索
  • 公共沟通和风险信息传递
  • 医疗系统准备
政策考量：
  • 预防和控制的资源分配
  • 公共卫生行动的法律权限（强制报告、隔离权）
  • 干预措施的公平可及性
  • 个人自由与集体保护的平衡
研究需求：
  • 病原体表征和毒力因素
  • 治疗和疫苗开发
  • 通过分析性研究识别风险因素
  • 干预措施有效性评估
  • 长期后遗症评估

Step-by-Step Analysis Process

分步分析流程

Step 1: Define the Health Event and Context

步骤1：定义健康事件与背景

Actions:
  • Clearly describe the health event or disease of interest
  • Identify affected population and geographic area
  • Determine whether this is outbreak, trend analysis, or policy evaluation
  • Gather background information on disease natural history, epidemiology, and public health significance
Tools/Frameworks:
  • Literature review of disease epidemiology
  • Review of previous outbreaks or studies
  • Surveillance data examination
Outputs:
  • Clear problem statement
  • Understanding of disease characteristics (incubation, transmission, severity)
  • Baseline disease incidence for comparison
  • Stakeholder identification
行动：
  • 清晰描述关注的健康事件或疾病
  • 确定受影响人群和地理区域
  • 确定这是暴发、趋势分析还是政策评估
  • 收集疾病自然史、流行病学和公共卫生重要性的背景信息
工具/框架：
  • 疾病流行病学文献回顾
  • 回顾既往暴发或研究
  • 检查监测数据
输出：
  • 清晰的问题陈述
  • 理解疾病特征（潜伏期、传播、严重程度）
  • 用于比较的基线疾病发病率
  • 利益相关方识别

Step 2: Verify and Characterize Cases

步骤2：验证并表征病例

Actions:
  • Confirm diagnosis through clinical evaluation and laboratory testing
  • Develop case definition (clinical, laboratory, and epidemiologic criteria)
  • Classify cases as confirmed, probable, or suspect
  • Conduct active case finding beyond passive surveillance
  • Review medical records and laboratory results
Tools/Frameworks:
  • Standard case definitions (CDC, WHO)
  • Laboratory protocols
  • Medical record abstraction forms
Outputs:
  • Standardized case definition
  • Complete line listing of cases with key variables
  • Laboratory confirmation results
  • Case count and preliminary attack rates
行动：
  • 通过临床评估和实验室检测确认诊断
  • 制定病例定义（临床、实验室、流行病学标准）
  • 将病例分类为确诊、可能或疑似
  • 在被动监测之外开展主动病例搜索
  • 审查医疗记录和实验室结果
工具/框架：
  • 标准化病例定义（CDC、WHO）
  • 实验室规程
  • 医疗记录提取表
输出：
  • 标准化病例定义
  • 包含关键变量的完整病例列表
  • 实验室确认结果
  • 病例数和初步罹患率

Step 3: Describe Cases by Person, Place, and Time

步骤3：按人群、地点和时间描述病例

Actions:
  • Person: Tabulate cases by age, sex, occupation, risk factors, underlying conditions
  • Place: Map case locations (residence, workplace, exposure sites), identify clusters
  • Time: Construct epidemic curve showing cases by date of onset, identify trends and patterns
Tools/Frameworks:
  • Epidemic curves (histograms by onset date)
  • Spot maps and geographic information systems (GIS)
  • Descriptive statistics (frequencies, proportions, rates)
Outputs:
  • Epidemic curve revealing outbreak pattern (point-source, propagated, mixed)
  • Geographic distribution maps showing clusters
  • Demographic characteristics of cases
  • Attack rates in different subgroups
  • Preliminary hypotheses about source and transmission
行动：
  • 人群：按年龄、性别、职业、风险因素、基础疾病制表
  • 地点：绘制病例位置图（居住地、工作场所、暴露场所），识别聚集性
  • 时间：构建显示发病日期的流行曲线，识别趋势和模式
工具/框架：
  • 流行曲线（按发病日期的直方图）
  • 斑点图和地理信息系统（GIS）
  • 描述性统计（频率、比例、率）
输出：
  • 揭示暴发模式（点源、传播性、混合）的流行曲线
  • 显示聚集性的地理分布图
  • 病例的人口统计学特征
  • 不同亚组的罹患率
  • 关于来源和传播的初步假设

Step 4: Generate Hypotheses About Source and Transmission

步骤4：生成关于来源和传播的假设

Actions:
  • Develop hypotheses about disease source based on descriptive epidemiology
  • Identify potential exposures from case interviews
  • Consider multiple transmission modes (person-to-person, common source, vector-borne)
  • Review scientific literature for known risk factors
  • Conduct environmental assessment of potential exposure sites
Tools/Frameworks:
  • Case interviews and questionnaires
  • Environmental inspections
  • Literature review
  • Biological plausibility assessment
Outputs:
  • List of potential sources and vehicles
  • Exposure timeline relative to epidemic curve
  • Priority hypotheses to test analytically
  • Environmental sampling plan
行动：
  • 根据描述性流行病学提出疾病来源的假设
  • 从病例访谈中识别潜在暴露
  • 考虑多种传播方式（人传人、共同来源、媒介传播）
  • 回顾已知风险因素的科学文献
  • 对潜在暴露场所进行环境评估
工具/框架：
  • 病例访谈和问卷
  • 环境检查
  • 文献回顾
  • 生物学合理性评估
输出：
  • 潜在来源和传播载体列表
  • 与流行曲线相关的暴露时间线
  • 需通过分析检验的优先级假设
  • 环境采样计划

Step 5: Test Hypotheses Using Analytic Studies

步骤5：使用分析性研究检验假设

Actions:
  • Select appropriate study design (cohort if population defined, case-control if not)
  • Design questionnaire assessing exposures of interest
  • Identify controls (if case-control) or define cohort (if cohort study)
  • Collect exposure data through interviews or records
  • Calculate measures of association (RR or OR) with confidence intervals
  • Assess statistical significance
  • Evaluate confounding and effect modification
Tools/Frameworks:
  • Cohort study or case-control study design
  • 2x2 tables for calculating RR or OR
  • Statistical software for multivariable analysis
  • Confounding assessment
Outputs:
  • Quantitative measures of association between exposures and disease
  • Statistical significance testing results
  • Identification of likely source or risk factors
  • Assessment of alternative explanations
行动：
  • 选择适当的研究设计（人群明确时用队列研究，否则用病例对照研究）
  • 设计评估关注暴露的问卷
  • 识别对照（如病例对照研究）或定义队列（如队列研究）
  • 通过访谈或记录收集暴露数据
  • 计算关联度量（RR或OR）及置信区间
  • 评估统计显著性
  • 评估混杂和效应修饰
工具/框架：
  • 队列研究或病例对照研究设计
  • 用于计算RR或OR的2x2表
  • 用于多变量分析的统计软件
  • 混杂评估
输出：
  • 暴露与疾病之间关联的定量度量
  • 统计显著性检验结果
  • 识别可能的来源或风险因素
  • 对替代解释的评估

Step 6: Conduct Environmental and Laboratory Investigations

步骤6：开展环境与实验室调查

Actions:
  • Inspect implicated sites (restaurants, facilities, water systems)
  • Collect environmental samples (food, water, surfaces)
  • Conduct laboratory testing of samples
  • Perform molecular typing of isolates from cases and environment
  • Trace sources backward through supply chain
Tools/Frameworks:
  • Environmental health protocols
  • Laboratory methods (culture, PCR, whole genome sequencing)
  • Traceback investigation procedures
Outputs:
  • Laboratory confirmation of pathogen in environmental samples
  • Molecular match between clinical and environmental isolates
  • Identification of specific contaminated product or site
  • Understanding of contamination or transmission pathway
行动：
  • 检查相关场所（餐厅、设施、供水系统）
  • 采集环境样本（食物、水、表面）
  • 对样本进行实验室检测
  • 对病例和环境分离株进行分子分型
  • 通过供应链溯源
工具/框架：
  • 环境卫生规程
  • 实验室方法（培养、PCR、全基因组测序）
  • 溯源调查程序
输出：
  • 环境样本中病原体的实验室确认
  • 临床与环境分离株的分子匹配
  • 识别特定受污染产品或场所
  • 理解污染或传播途径

Step 7: Implement Control and Prevention Measures

步骤7：实施控制与预防措施

Actions:
  • Stop exposure source (product recalls, facility closures, contamination remediation)
  • Prevent secondary transmission (isolation, quarantine, prophylaxis)
  • Enhance surveillance for additional cases
  • Communicate with public and healthcare providers
  • Provide guidance on prevention
Tools/Frameworks:
  • Public health legal authorities
  • Communication strategies
  • Infection control guidelines
  • Vaccination or prophylaxis protocols
Outputs:
  • Control measures implemented
  • Outbreak stopped (no new cases)
  • Public awareness of prevention strategies
  • Healthcare provider alerts
行动：
  • 终止暴露来源（产品召回、场所关闭、污染 remediation）
  • 阻止二代传播（隔离、检疫、预防用药）
  • 加强监测以发现新增病例
  • 与公众和医疗服务提供者沟通
  • 提供预防指导
工具/框架：
  • 公共卫生法律权限
  • 沟通策略
  • 感染控制指南
  • 疫苗接种或预防用药规程
输出：
  • 实施的控制措施
  • 暴发终止（无新增病例）
  • 公众了解预防策略
  • 医疗服务提供者警报

Step 8: Evaluate Intervention Effectiveness

步骤8：评估干预措施有效性

Actions:
  • Monitor disease incidence after intervention
  • Compare observed trajectory to predicted trajectory
  • Assess intervention coverage and compliance
  • Identify barriers to implementation
  • Document lessons learned
Tools/Frameworks:
  • Time series analysis
  • Before-after comparisons
  • Process evaluation methods
Outputs:
  • Evidence of intervention impact (decline in cases)
  • Identification of successful and unsuccessful components
  • Recommendations for future interventions
行动：
  • 监测干预后的疾病发病率
  • 将观察到的轨迹与预测轨迹比较
  • 评估干预覆盖率和依从性
  • 识别实施障碍
  • 记录经验教训
工具/框架：
  • 时间序列分析
  • 前后比较
  • 过程评估方法
输出：
  • 干预措施影响的证据（病例减少）
  • 识别成功和不成功的组件
  • 未来干预措施的建议

Step 9: Communicate Findings and Recommendations

步骤9：沟通发现与建议

Actions:
  • Prepare outbreak investigation report
  • Present findings to stakeholders (health department, community, facilities)
  • Submit findings to scientific literature if appropriate
  • Develop recommendations for prevention
  • Update public health guidelines if needed
Tools/Frameworks:
  • MMWR (Morbidity and Mortality Weekly Report) format
  • Scientific manuscript structure
  • Plain-language summaries for public
Outputs:
  • Comprehensive outbreak report
  • Scientific publications
  • Policy recommendations
  • Training materials for future investigations
  • Surveillance enhancements
行动：
  • 准备暴发调查报告
  • 向利益相关方（卫生部门、社区、设施）呈现发现
  • 如合适，向科学文献提交发现
  • 制定预防建议
  • 如需要，更新公共卫生指南
工具/框架：
  • MMWR（Morbidity and Mortality Weekly Report）格式
  • 科学手稿结构
  • 面向公众的通俗易懂摘要
输出：
  • 全面的暴发报告
  • 科学出版物
  • 政策建议
  • 未来调查的培训材料
  • 监测改进措施

Usage Examples

使用示例

Example 1: Foodborne Illness Outbreak at Wedding

示例1：婚礼食源性疾病暴发

Event: Local health department receives reports of acute gastroenteritis among attendees of a wedding reception on Saturday evening. By Tuesday, 45 guests report illness.
Analysis Process:
Step 1 - Define Event: Wedding reception with 200 guests at hotel ballroom on Saturday 6pm-11pm. Guests report vomiting and diarrhea beginning 2-48 hours after event. Need to determine: What caused illnesses? How many are affected? What control measures needed?
Step 2 - Verify Cases: Case definition: Wedding guest with vomiting or diarrhea beginning 6 hours to 3 days after reception. Active case finding through guest list contacts identifies 62 ill persons (cases) and 138 well persons. Clinical presentation consistent with viral gastroenteritis (short incubation, vomiting, diarrhea, resolution in 1-2 days). Stool specimens from 5 cases test positive for norovirus by PCR.
Step 3 - Describe Cases:
  • Person: Attack rate 31% (62/200). Cases similar to non-cases by age and sex.
  • Time: Epidemic curve shows sharp peak at 24 hours post-event, with all cases within 48 hours. Pattern consistent with point-source exposure.
  • Place: Cases from multiple geographic areas, linked only by wedding attendance. No secondary cases reported.
Step 4 - Generate Hypotheses: Point-source epidemic curve suggests common exposure at reception. Short incubation (median 24 hours) consistent with norovirus from contaminated food or infected food handler. Hypotheses: contaminated food items served at reception.
Step 5 - Analytic Study: Retrospective cohort study of all 200 guests. Questionnaire assesses all food items consumed. Calculate attack rates and relative risks for each food item:
Results:
  • Ate wedding cake: 58/150 ill (39% attack rate)
  • Did not eat cake: 4/50 ill (8% attack rate)
  • Relative Risk = 4.8 (95% CI: 1.8-12.7, p<0.001)
Other foods not significantly associated. Wedding cake strongly associated with illness.
Step 6 - Environmental Investigation: Inspection of hotel kitchen and interview of food handlers. Pastry chef worked while ill with vomiting/diarrhea on Friday (day before wedding), handled cake after baking (no gloves). Stool specimen from chef positive for norovirus, genotype matches cases.
Step 7 - Control Measures:
  • Hotel chef excluded from work until 48 hours after symptom resolution
  • Hotel staff trained on ill worker exclusion policies and proper handwashing
  • Hotel implements policy requiring gloves for handling ready-to-eat foods
  • No further events at hotel affected (no additional cake prepared by ill chef)
Step 8 - Evaluation: No secondary transmission from wedding-associated cases. Hotel implements permanent policy changes preventing future outbreaks from ill food handlers. Success demonstrated by no subsequent outbreaks at venue over following year.
Step 9 - Communication: Report provided to hotel management with recommendations. Summary provided to wedding hosts. Outbreak report submitted to state health department and published in MMWR. Case study used in food handler training.
Key Findings:
  • 62 cases of norovirus gastroenteritis linked to wedding reception (attack rate 31%)
  • Wedding cake was vehicle (RR=4.8)
  • Contamination from ill food handler who worked while symptomatic
  • Outbreak prevented future cases through policy changes
Frameworks Applied:
  • Outbreak investigation (10 steps)
  • Cohort study design
  • Epidemic curve construction
  • Relative risk calculation
  • Bradford Hill causality criteria (strength, temporality, consistency, plausibility)
Sources Referenced:
  • Norovirus incubation period and clinical presentation (CDC)
  • Outbreak investigation methodology (CDC Field Epi Manual)
  • Food handler exclusion policies (FDA Food Code)
事件：当地卫生部门接到婚礼晚宴参与者急性胃肠炎的报告。截至周二，45名宾客报告患病。
分析流程：
步骤1 - 定义事件： 周六晚6点至11点在酒店宴会厅举办的婚礼晚宴，有200名宾客。宾客报告在事件后2-48小时出现呕吐和腹泻。需确定：病因是什么？受影响人数是多少？需要哪些控制措施？
步骤2 - 验证病例： 病例定义：婚礼宾客在晚宴后6小时至3天内出现呕吐或腹泻。通过宾客名单联系开展主动病例搜索，识别出62名患者（病例）和138名健康者。临床表型符合病毒性胃肠炎（短潜伏期、呕吐、腹泻、1-2天内恢复）。5名病例的粪便标本经PCR检测呈诺如病毒阳性。
步骤3 - 描述病例：
  • 人群：罹患率31%（62/200）。病例与非病例在年龄和性别上无差异。
  • 时间：流行曲线显示事件后24小时出现尖锐峰值，所有病例在48小时内。模式与点源暴露一致。
  • 地点：病例来自多个地理区域，仅通过婚礼 attendance 关联。无二代病例报告。
步骤4 - 生成假设： 点源流行曲线提示晚宴存在共同暴露。短潜伏期（中位24小时）与诺如病毒污染食物或受感染食品加工者一致。假设：晚宴供应的受污染食物。
步骤5 - 分析性研究： 对所有200名宾客开展回顾性队列研究。问卷评估所有食用的食物项目。计算每个食物项目的罹患率和相对风险：
结果：
  • 食用婚礼蛋糕：150人中有58人患病（39%罹患率）
  • 未食用蛋糕：50人中有4人患病（8%罹患率）
  • 相对风险 = 4.8（95% CI: 1.8-12.7，p<0.001）
其他食物无显著关联。婚礼蛋糕与患病强相关。
步骤6 - 环境调查： 检查酒店厨房并访谈食品加工者。糕点厨师在周五（婚礼前一天）出现呕吐/腹泻症状仍继续工作，在烘焙后处理蛋糕（未戴手套）。厨师的粪便标本诺如病毒阳性，基因型与病例匹配。
步骤7 - 控制措施：
  • 酒店厨师在症状消失后48小时内不得工作
  • 酒店员工接受患病员工排除政策和正确洗手培训
  • 酒店实施处理即食食品需戴手套的政策
  • 酒店未发生后续事件（患病厨师未制作其他蛋糕）
步骤8 - 评估： 婚礼相关病例未发生二代传播。酒店实施永久政策变更，防止未来因患病食品加工者引发暴发。成功表现为未来一年场地未发生后续暴发。
步骤9 - 沟通： 向酒店管理层提交含建议的报告。向婚礼主办方提供摘要。暴发报告提交至州卫生部门并发表于MMWR。案例用于食品加工者培训。
关键发现：
  • 62例诺如病毒胃肠炎与婚礼晚宴相关（罹患率31%）
  • 婚礼蛋糕为传播载体（RR=4.8）
  • 由出现症状仍工作的患病食品加工者污染
  • 通过政策变更防止未来病例
应用的框架：
  • 暴发调查（10步）
  • 队列研究设计
  • 流行曲线构建
  • 相对风险计算
  • Bradford Hill因果标准（强度、时序性、一致性、合理性）
参考资料：
  • 诺如病毒潜伏期和临床表型（CDC）
  • 暴发调查方法学（CDC现场流行病学手册）
  • 食品加工者排除政策（FDA食品法典）

Example 2: Evaluation of School-Based Vaccination Program

示例2：学校疫苗接种项目评估

Event: School district implements new policy requiring HPV vaccination for school entry. After one year, district requests evaluation of program effectiveness and equity.
Analysis Process:
Step 1 - Define Event: District policy requires students entering 7th grade to have HPV vaccine series (3 doses) or exemption. Policy goal: increase vaccination coverage to >80% to prevent HPV-associated cancers. Need to evaluate: Did coverage increase? Were there disparities? What were barriers?
Step 2 - Data Collection: Obtain vaccination records for all 7th graders in district (N=5,000) for two years: year before policy (baseline) and year after policy (intervention). Link to student demographic data (age, sex, race/ethnicity, insurance status, school attended). Review exemption forms.
Step 3 - Describe Vaccination Coverage: Overall coverage:
  • Baseline year: 42% completed series
  • Intervention year: 76% completed series
  • Absolute increase: 34 percentage points
Stratified by demographics:
SubgroupBaselineInterventionChange
Overall42%76%+34%
Female58%85%+27%
Male26%67%+41%
White48%81%+33%
Black35%68%+33%
Hispanic40%74%+34%
Insured45%78%+33%
Uninsured28%68%+40%
Exemptions: 8% claimed exemption (5% religious, 3% medical)
Step 4 - Assess Disparities: Baseline: Large gender gap (58% vs 26%), smaller disparities by race/ethnicity and insurance. Intervention year: Gender gap reduced but persists (85% vs 67%). Racial/ethnic gaps narrowed. Insurance gap narrowed substantially.
Step 5 - Evaluate Access Barriers: Survey sample of parents (n=500) about vaccination experience:
  • 82% found it easy to get vaccine
  • 15% reported difficulty getting appointments
  • 8% concerned about cost (mostly uninsured)
  • 12% reported vaccine hesitancy
  • School-based vaccine clinics reached 35% of students
School-based clinics particularly effective for uninsured students (62% of uninsured students vaccinated at school vs 18% of insured students).
Step 6 - Assess Program Implementation: Review implementation fidelity:
  • All schools sent reminder letters: 100%
  • Schools held vaccine clinics: 80% (lower in small schools)
  • Exemption process standardized: Yes
  • Student exclusions for non-compliance: 45 students (0.9%)
Cost analysis:
  • Program cost: $250,000 (includes vaccine, staff, clinics)
  • Students newly vaccinated: 1,700
  • Cost per newly vaccinated: $147
  • Future cancer cases prevented (estimated): 17
  • Cost per cancer prevented: $14,700 (highly cost-effective)
Step 7 - Model Long-Term Impact: Using HPV vaccination effectiveness data (90% reduction in HPV 16/18 infections, 70% reduction in cervical cancer), estimate that vaccinating 1,700 additional students will prevent:
  • 1,200 HPV infections
  • 17 cervical cancers
  • 5 other HPV-associated cancers
  • 4 cancer deaths
  • Lifetime healthcare cost savings: $6.8 million
Step 8 - Identify Remaining Gaps: Despite success, coverage below goal in several groups:
  • Males (67% vs goal of 80%)
  • Students at small schools without clinics (58%)
  • Families claiming exemptions (8%)
Barriers identified:
  • Vaccine hesitancy (especially for males)
  • Access challenges in small/rural schools
  • Misinformation about vaccine safety
Step 9 - Recommendations: Continue program with enhancements:
  1. Expand school clinics to all schools (partner with county health dept for small schools)
  2. Enhance education targeting parents of male students
  3. Address misinformation through healthcare provider communication
  4. Improve appointment access through extended hours and mobile clinics
  5. Monitor coverage annually by subgroup to ensure equity
Key Findings:
  • School-entry requirement increased HPV vaccination coverage from 42% to 76% (+34 percentage points)
  • Program reduced gender gap and nearly eliminated insurance-related disparities
  • School-based clinics critical for reaching uninsured students
  • Program highly cost-effective ($147 per newly vaccinated student)
  • Estimated to prevent 22 cancers and 4 deaths in this cohort
  • Remaining gaps in males and small schools require targeted interventions
Frameworks Applied:
  • Program evaluation methodology
  • Prevalence measures (vaccination coverage)
  • Stratified analysis to assess equity
  • Survey methods for barrier assessment
  • Mathematical modeling for impact projection
  • Cost-effectiveness analysis
Sources Referenced:
  • HPV vaccine effectiveness studies (Cochrane Review)
  • Cancer incidence rates (SEER database)
  • Vaccination coverage benchmarks (Healthy People 2030)
  • Cost-effectiveness thresholds (WHO guidelines)
事件：学区实施新政策，要求学生入学时接种HPV疫苗。一年后，学区要求评估项目有效性和公平性。
分析流程：
步骤1 - 定义事件： 学区政策要求7年级学生完成HPV疫苗系列（3剂）或获得豁免。政策目标：将疫苗接种覆盖率提升至>80%以预防HPV相关癌症。需评估：覆盖率是否提升？是否存在差异？障碍是什么？
步骤2 - 数据收集： 获取学区所有7年级学生（N=5,000）两年的疫苗接种记录：政策实施前一年（基线）和实施后一年（干预）。链接至学生人口统计学数据（年龄、性别、种族/民族、保险状态、就读学校）。审查豁免表格。
步骤3 - 描述疫苗接种覆盖率： 总体覆盖率：
  • 基线年：42%完成系列接种
  • 干预年：76%完成系列接种
  • 绝对增长：34个百分点
按人口统计学分层：
亚组基线干预变化
总体42%76%+34%
女性58%85%+27%
男性26%67%+41%
白人48%81%+33%
黑人35%68%+33%
西班牙裔40%74%+34%
有保险45%78%+33%
无保险28%68%+40%
豁免：8%申请豁免（5%宗教豁免，3%医疗豁免）
步骤4 - 评估差异： 基线：性别差距大（58% vs 26%），种族/民族和保险差异较小。 干预年：性别差距缩小但仍存在（85% vs 67%）。种族/民族差距缩小。保险差距大幅缩小。
步骤5 - 评估可及性障碍： 对家长样本（n=500）开展疫苗接种体验调查：
  • 82%认为接种疫苗容易
  • 15%报告预约困难
  • 8%担心成本（主要为无保险者）
  • 12%报告疫苗犹豫
  • 学校疫苗接种诊所覆盖35%的学生
学校诊所对无保险学生尤其有效（62%的无保险学生在学校接种，而有保险学生为18%）。
步骤6 - 评估项目实施： 审查实施 fidelity：
  • 所有学校发送提醒信：100%
  • 学校举办疫苗诊所：80%（小型学校比例较低）
  • 豁免流程标准化：是
  • 因不遵守规定被排除的学生：45名（0.9%）
成本分析：
  • 项目成本：250,000美元（包括疫苗、人员、诊所）
  • 新增接种学生：1,700名
  • 每新增1名接种学生成本：147美元
  • 预防的未来癌症病例（估算）：17例
  • 每预防1例癌症成本：14,700美元（极具成本效益）
步骤7 - 建模长期影响： 使用HPV疫苗有效性数据（HPV 16/18感染减少90%，宫颈癌减少70%），估算新增接种的1,700名学生将预防：
  • 1,200例HPV感染
  • 17例宫颈癌
  • 5例其他HPV相关癌症
  • 4例癌症死亡
  • 终身医疗成本节约：680万美元
步骤8 - 识别剩余差距： 尽管成功，部分群体覆盖率低于目标：
  • 男性（67% vs 目标80%）
  • 无诊所的小型学校学生（58%）
  • 申请豁免的家庭（8%）
识别的障碍：
  • 疫苗犹豫（尤其针对男性）
  • 小型/农村学校的可及性挑战
  • 疫苗安全性的错误信息
步骤9 - 建议： 继续项目并加强：
  1. 扩展学校诊所至所有学校（与县卫生部门合作覆盖小型学校）
  2. 加强教育针对男性学生家长
  3. 通过医疗服务提供者沟通解决错误信息
  4. 通过延长时间和流动诊所改善预约可及性
  5. 每年按亚组监测覆盖率以确保公平性
关键发现：
  • 入学要求使HPV疫苗接种覆盖率从42%提升至76%（+34个百分点）
  • 项目缩小了性别差距并几乎消除了保险相关差异
  • 学校诊所对覆盖无保险学生至关重要
  • 项目极具成本效益（每新增1名接种学生147美元）
  • 估算将预防该队列22例癌症和4例死亡
  • 男性和小型学校的剩余差距需要靶向干预
应用的框架：
  • 项目评估方法学
  • 患病率度量（疫苗接种覆盖率）
  • 分层分析以评估公平性
  • 障碍评估的调查方法
  • 影响预测的数学建模
  • 成本效益分析
参考资料：
  • HPV疫苗有效性研究（Cochrane综述）
  • 癌症发病率（SEER数据库）
  • 疫苗接种覆盖率基准（健康人民2030）
  • 成本效益阈值（WHO指南）

Example 3: COVID-19 Outbreak in Long-Term Care Facility

示例3：长期护理机构COVID-19暴发

Event: Long-term care facility (LTCF) with 120 residents and 80 staff reports cluster of respiratory illness. Within 5 days, 18 residents test positive for COVID-19.
Analysis Process:
Step 1 - Define Event: LTCF outbreak of COVID-19 detected January 10. Facility has 3 units (A, B, C) with 40 residents each. Community transmission moderate (50 cases per 100K per day). Need to: Determine outbreak extent, identify source, implement control measures, prevent additional cases.
Step 2 - Case Finding and Verification: Case definition: LTCF resident or staff with positive SARS-CoV-2 PCR or antigen test starting January 5 (one week before outbreak recognition).
Active surveillance: Test all residents and staff immediately (universal testing).
Results (Day 1 testing):
  • Residents: 18/120 positive (15%)
  • Staff: 4/80 positive (5%)
  • Total: 22 cases
Repeat testing every 3 days to identify new cases early.
Step 3 - Describe Cases:
By Unit:
  • Unit A: 2/40 residents (5%)
  • Unit B: 14/40 residents (35%)
  • Unit C: 2/40 residents (5%)
Outbreak concentrated in Unit B.
By Time (Epidemic Curve): Constructed epidemic curve by symptom onset date:
  • January 5-7: 3 cases (1 staff, 2 residents Unit B)
  • January 8-10: 8 cases (all residents Unit B)
  • January 11-13: 11 cases (2 staff, 9 residents Unit B and others)
Pattern suggests: Initial introduction to Unit B (January 5), followed by rapid spread within Unit B (January 8-10), then spillover to other units (January 11-13).
Clinical Severity:
  • Asymptomatic: 5 (23%)
  • Mild symptoms: 10 (45%)
  • Hospitalized: 5 (23%)
  • Deaths: 2 (9%)
Step 4 - Source Investigation: Hypothesis: Staff member introduced virus to Unit B, leading to resident-to-resident and staff-to-resident transmission.
Evidence:
  • Staff case 1 (Unit B aide) had symptom onset January 5, worked January 5-6 while pre-symptomatic
  • Whole genome sequencing: 20/22 cases have identical variant (Delta)
  • 2 cases (Unit A, Unit C) have different variant → community-acquired, not outbreak-associated
  • Staff survey: 1 staff member floated between units during outbreak period
Conclusion: Staff case 1 likely introduced virus to Unit B. Rapid spread within Unit B due to shared spaces, close contact during care, and asymptomatic transmission.
Step 5 - Assess Vaccination Status and Breakthrough Infections: Facility vaccination coverage (baseline):
  • Residents: 85% fully vaccinated
  • Staff: 62% fully vaccinated
Attack rates by vaccination status (Unit B only):
GroupVaccinatedUnvaccinated
Residents25% (7/28)58% (7/12)
Staff10% (1/10)30% (3/10)
Vaccines providing protection but breakthrough infections occurring. Unvaccinated at much higher risk.
Step 6 - Implement Control Measures:
Immediate actions (Day 1-3):
  1. Isolate cases: Move to isolation rooms or cohort Unit B
  2. Quarantine exposed: All Unit B residents quarantined to rooms
  3. Universal PPE: N95 respirators, gowns, gloves for all resident contact
  4. Stop communal activities: No dining room, activities, or group events
  5. Restrict admissions: No new admissions until outbreak controlled
  6. Suspend visitation: Limited to compassionate care only
  7. Dedicate staff: Unit B staff do not work other units; no floating
  8. Enhance cleaning: Increase frequency, focus on high-touch surfaces
Additional measures (Day 4-7): 9. Test frequently: All residents and staff every 3 days 10. Antiviral treatment: Offer Paxlovid to high-risk residents 11. Boost vaccinations: Offer boosters to all unboosted residents/staff 12. Enhance ventilation: Open windows, use portable HEPA filters
Step 7 - Monitor Outbreak Trajectory:
Serial testing results:
  • Day 1: 22 cases
  • Day 4: 8 new cases (30 total)
  • Day 7: 2 new cases (32 total)
  • Day 10: 0 new cases (32 total)
  • Day 14: 0 new cases (declare outbreak controlled)
Epidemic curve shows control measures effective. New cases declining after Day 4.
Final case count: 32 cases (27 residents, 5 staff)
  • Residents: Attack rate 23% overall, 60% in Unit B
  • Staff: Attack rate 6%
  • Hospitalizations: 7 (22%)
  • Deaths: 3 (9%)
Step 8 - Evaluate Contributing Factors:
Vulnerability factors:
  • High-risk population (elderly, comorbidities)
  • Congregate setting with shared spaces
  • Close contact during care activities
  • Asymptomatic transmission (23% of cases)
  • Suboptimal staff vaccination (62%)
Protective factors:
  • High resident vaccination reduced attack rates and severity
  • Rapid detection through testing
  • Immediate isolation and cohorting
  • Dedicated staffing prevented wider spread
  • Antiviral treatment reduced hospitalizations
Lessons learned:
  • Staff vaccination critical (case introduced by staff)
  • Universal testing enabled early detection
  • Rapid control measures contained outbreak to primarily one unit
  • Boosters needed for sustained protection against variants
Step 9 - Recommendations for Prevention:
For this facility:
  1. Require staff vaccination (mandate if needed)
  2. Implement regular staff screening testing (weekly)
  3. Maintain PPE supply and training
  4. Review ventilation systems and air quality
  5. Develop outbreak response plan for future events
  6. Offer booster doses every 6 months to residents
For other LTCFs:
  1. Achieve >90% staff vaccination coverage
  2. Implement routine surveillance testing of staff
  3. Prepare outbreak response supplies (isolation capacity, PPE, testing)
  4. Train staff on infection control and outbreak response
  5. Coordinate with health department for rapid investigation support
Policy implications:
  • Staff vaccination mandates reduce introduction risk
  • Federal regulations should require regular testing and outbreak response plans
  • Boosters needed for high-risk populations every 6 months
  • Antiviral availability critical for outbreak response
Key Findings:
  • 32 cases (27 residents, 5 staff) in LTCF COVID-19 outbreak
  • Introduced by staff member, spread rapidly in Unit B
  • Rapid control measures contained outbreak within 2 weeks
  • Vaccination reduced attack rates by 50% and severity
  • 3 deaths (9% case fatality rate)
  • Recommendations focus on staff vaccination and surveillance testing
Frameworks Applied:
  • Outbreak investigation (10 steps)
  • Disease surveillance (universal testing)
  • Epidemic curve construction and interpretation
  • Attack rate calculation stratified by vaccination status
  • Cohort study design (comparing vaccinated vs. unvaccinated)
  • Vaccine effectiveness estimation
  • Intervention evaluation (control measures)
Sources Referenced:
  • CDC Long-Term Care Facility COVID-19 Guidance
  • CDC Interim Infection Prevention and Control Recommendations
  • COVID-19 vaccine effectiveness studies (MMWR)
  • Whole genome sequencing protocols (CDC)
  • Antiviral treatment guidelines (NIH)
事件：拥有120名居民和80名员工的长期护理机构（LTCF）报告呼吸道疾病聚集性病例。5天内，18名居民SARS-CoV-2检测阳性。
分析流程：
步骤1 - 定义事件： LTCF于1月10日检测到COVID-19暴发。机构有3个单元（A、B、C），每个单元40名居民。社区传播中度（每10万人50例/天）。需：确定暴发范围、识别来源、实施控制措施、预防新增病例。
步骤2 - 病例搜索与验证： 病例定义：LTCF居民或员工在1月5日（暴发识别前一周）起SARS-CoV-2 PCR或抗原检测阳性。
主动监测：立即对所有居民和员工进行普筛。
结果（第1天检测）：
  • 居民：18/120阳性（15%）
  • 员工：4/80阳性（5%）
  • 总计：22例
每3天重复检测以早期发现新增病例。
步骤3 - 描述病例：
按单元：
  • 单元A：2/40居民（5%）
  • 单元B：14/40居民（35%）
  • 单元C：2/40居民（5%）
暴发集中在单元B。
按时间（流行曲线）： 按症状 onset 日期构建流行曲线：
  • 1月5-7日：3例（1名员工，2名单元B居民）
  • 1月8-10日：8例（均为单元B居民）
  • 1月11-13日：11例（2名员工，9名单元B及其他单元居民）
模式提示：1月5日引入单元B，随后在单元B快速传播（1月8-10日），然后扩散至其他单元（1月11-13日）。
临床严重程度：
  • 无症状：5例（23%）
  • 轻度症状：10例（45%）
  • 住院：5例（23%）
  • 死亡：2例（9%）
步骤4 - 来源调查： 假设：员工将病毒引入单元B，导致居民间及员工-居民传播。
证据：
  • 员工病例1（单元B助手）于1月5日出现症状，1月5-6日症状前工作
  • 全基因组测序：20/22例病例具有相同变异株（Delta）
  • 2例（单元A、单元C）具有不同变异株 → 社区获得性，与暴发无关
  • 员工调查：1名员工在暴发期间跨单元流动
结论：员工病例1可能将病毒引入单元B。由于共享空间、护理期间密切接触和无症状传播，单元B内快速传播。
步骤5 - 评估疫苗接种状态与突破感染： 机构疫苗接种覆盖率（基线）：
  • 居民：85%完全接种
  • 员工：62%完全接种
按疫苗接种状态的罹患率（仅单元B）：
群体接种疫苗未接种疫苗
居民25% (7/28)58% (7/12)
员工10% (1/10)30% (3/10)
疫苗提供保护，但仍发生突破感染。未接种者风险高得多。
步骤6 - 实施控制措施：
立即行动（第1-3天）：
  1. 隔离病例：转移至隔离室或集中管理单元B
  2. 隔离暴露者：所有单元B居民在房间隔离
  3. 通用PPE：所有居民接触时使用N95呼吸器、隔离衣、手套
  4. 停止集体活动：关闭餐厅、活动或团体项目
  5. 限制入院：暴发控制前不接收新患者
  6. 暂停探视：仅允许同情性探视
  7. 员工固定单元：单元B员工不跨单元工作；禁止流动
  8. 加强清洁：增加频率，聚焦高频接触表面
额外措施（第4-7天）：9. 频繁检测：所有居民和员工每3天检测一次 10. 抗病毒治疗：为高风险居民提供Paxlovid 11. 加强接种：为所有未加强接种的居民/员工提供加强针 12. 加强通风：开窗、使用便携式HEPA过滤器
步骤7 - 监测暴发轨迹：
系列检测结果：
  • 第1天：22例
  • 第4天：8例新增（总计30例）
  • 第7天：2例新增（总计32例）
  • 第10天：0例新增（总计32例）
  • 第14天：0例新增（宣布暴发控制）
流行曲线显示控制措施有效。第4天后新增病例减少。
最终病例数：32例（27名居民，5名员工）
  • 居民：总体罹患率23%，单元B60%
  • 员工：罹患率6%
  • 住院：7例（22%）
  • 死亡：3例（9%）
步骤8 - 评估促成因素：
脆弱性因素：
  • 高风险人群（老年人、合并症）
  • 集体居住环境，共享空间
  • 护理期间密切接触
  • 无症状传播（23%的病例）
  • 员工疫苗接种率不理想（62%）
保护因素：
  • 高居民疫苗接种率降低罹患率和严重程度
  • 通过检测快速发现
  • 立即隔离和集中管理
  • 员工固定单元防止更广泛传播
  • 抗病毒治疗减少住院
经验教训：
  • 员工疫苗接种至关重要（病例由员工引入）
  • 普筛实现早期发现
  • 快速控制措施将暴发限制在主要一个单元
  • 针对变异株需要加强接种以维持保护
步骤9 - 预防建议：
针对该机构：
  1. 要求员工接种疫苗（必要时强制）
  2. 实施员工定期筛查检测（每周）
  3. 维持PPE供应和培训
  4. 审查通风系统和空气质量
  5. 制定未来事件的暴发响应计划
  6. 每6个月为居民提供加强针
针对其他LTCF：
  1. 实现>90%员工疫苗接种覆盖率
  2. 实施员工常规监测检测
  3. 准备暴发响应物资（隔离能力、PPE、检测）
  4. 培训员工感染控制和暴发响应
  5. 与卫生部门协调以获得快速调查支持
政策影响：
  • 员工疫苗强制要求降低引入风险
  • 联邦法规应要求定期检测和暴发响应计划
  • 高风险人群每6个月需要加强接种
  • 抗病毒药物可及性对暴发响应至关重要
关键发现：
  • LTCF COVID-19暴发共32例（27名居民，5名员工）
  • 由员工引入，在单元B快速传播
  • 快速控制措施在2周内控制暴发
  • 疫苗接种使罹患率降低50%并减轻严重程度
  • 3例死亡（9%病死率）
  • 建议聚焦员工疫苗接种和监测检测
应用的框架：
  • 暴发调查（10步）
  • 疾病监测（普筛）
  • 流行曲线构建与解读
  • 按疫苗接种状态计算罹患率
  • 队列研究设计（比较接种与未接种）
  • 疫苗有效性估算
  • 干预措施评估（控制措施）
参考资料：
  • CDC长期护理机构COVID-19指南
  • CDC临时感染预防与控制建议
  • COVID-19疫苗有效性研究（MMWR）
  • 全基因组测序规程（CDC）
  • 抗病毒治疗指南（NIH）

Reference Materials (Expandable)

参考资料（可扩展）

Key Thinkers and Founding Figures

关键学者与奠基者

John Snow (1813-1858)
  • Contributions: Father of modern epidemiology, cholera investigation, disease mapping
  • Work: Removed Broad Street pump handle to stop 1854 London cholera outbreak; demonstrated waterborne transmission through natural experiment comparing water companies
  • Legacy: Established principles of outbreak investigation, environmental epidemiology, and evidence-based public health action
Louis Pasteur (1822-1895)
  • Contributions: Germ theory, vaccination, pasteurization
  • Work: Proved microorganisms cause disease; developed rabies and anthrax vaccines
  • Legacy: Foundation for infectious disease epidemiology and prevention
Robert Koch (1843-1910)
  • Contributions: Koch's postulates for proving causation, bacteriology
  • Work: Identified causative agents of tuberculosis, cholera, anthrax
  • Legacy: Established criteria for linking specific microorganisms to specific diseases
Austin Bradford Hill (1897-1991)
  • Contributions: Bradford Hill criteria for causal inference, randomized controlled trials
  • Work: Demonstrated smoking causes lung cancer through cohort studies
  • Legacy: Framework for evaluating causation from observational data remains standard
Wade Hampton Frost (1880-1938)
  • Contributions: Academic epidemiology, epidemiological methods
  • Work: First professor of epidemiology in US (Johns Hopkins), developed quantitative methods
  • Legacy: Established epidemiology as academic discipline with rigorous methodology
John Snow（1813-1858）
  • 贡献：现代流行病学之父，霍乱调查，疾病制图
  • 工作：移除宽街水泵手柄以终止1854年伦敦霍乱暴发；通过比较供水公司的自然实验证明水传播
  • 遗产：确立暴发调查、环境流行病学和循证公共卫生行动的原则
Louis Pasteur（1822-1895）
  • 贡献：微生物理论，疫苗接种，巴氏消毒法
  • 工作：证明微生物引发疾病；开发狂犬病和炭疽疫苗
  • 遗产：传染病流行病学和预防的基础
Robert Koch（1843-1910）
  • 贡献：科赫法则用于证明因果关系，细菌学
  • 工作：识别结核、霍乱、炭疽的病原体
  • 遗产：确立将特定微生物与特定疾病关联的标准
Austin Bradford Hill（1897-1991）
  • 贡献：Bradford Hill因果推断标准，随机对照试验
  • 工作：通过队列研究证明吸烟导致肺癌
  • 遗产：评估观察数据因果关系的框架仍是标准
Wade Hampton Frost（1880-1938）
  • 贡献：学术流行病学，流行病学方法
  • 工作：美国首位流行病学教授（约翰霍普金斯），开发定量方法
  • 遗产：确立流行病学为具有严谨方法学的学科

Professional Associations

专业协会

American Public Health Association (APHA) - Epidemiology Section
Society for Epidemiologic Research (SER)
  • Website: https://epiresearch.org/
  • Professional society for epidemiologists
  • Publications: American Journal of Epidemiology
  • Annual meeting showcases latest epidemiologic research
American College of Epidemiology (ACE)
  • Website: https://www.acepidemiology.org/
  • Promotes professional development and ethical practice
  • Offers certification in epidemiology
  • Publishes Annals of Epidemiology
Council of State and Territorial Epidemiologists (CSTE)
  • Website: https://www.cste.org/
  • Applied epidemiologists in state and local health departments
  • Develops standardized case definitions
  • Coordinates surveillance and outbreak response
International Epidemiological Association (IEA)
  • Website: https://www.ieaweb.org/
  • Global organization promoting epidemiology worldwide
  • Regional groups (North America, Europe, Asia, etc.)
  • Triennial World Congress of Epidemiology
美国公共卫生协会（APHA）- 流行病学分会
流行病学研究学会（SER）
  • 网站：https://epiresearch.org/
  • 流行病学家专业学会
  • 出版物：American Journal of Epidemiology
  • 年会展示最新流行病学研究
美国流行病学院（ACE）
州和地区流行病学家委员会（CSTE）
  • 网站：https://www.cste.org/
  • 州和地方卫生部门的应用流行病学家
  • 开发标准化病例定义
  • 协调监测和暴发响应
国际流行病学协会（IEA）
  • 网站：https://www.ieaweb.org/
  • 全球推广流行病学的组织
  • 区域小组（北美、欧洲、亚洲等）
  • 每三年举办一次世界流行病学大会

Leading Journals

顶级期刊

American Journal of Epidemiology
  • Society for Epidemiologic Research flagship journal
  • Methods and applications across all epidemiologic domains
  • Impact factor: 5.0+
Epidemiology
  • International Society for Environmental Epidemiology
  • Methods, environmental, occupational, and clinical epidemiology
  • Known for rigorous methodological standards
Morbidity and Mortality Weekly Report (MMWR)
  • CDC publication
  • Timely outbreak reports, surveillance summaries, recommendations
  • Open access, rapid publication
  • Website: https://www.cdc.gov/mmwr/
Emerging Infectious Diseases
  • CDC journal focused on emerging infections
  • Open access, peer-reviewed
  • Outbreak investigations, surveillance, trends
  • Website: https://wwwnc.cdc.gov/eid/
The Lancet Infectious Diseases
  • High-impact infectious disease journal
  • Global perspectives on infectious threats
  • Policy-relevant research
International Journal of Epidemiology
  • International Epidemiological Association journal
  • Methods, theory, and practice
  • Global health focus
American Journal of Epidemiology
  • 流行病学研究学会旗舰期刊
  • 涵盖所有流行病学领域的方法与应用
  • 影响因子：5.0+
Epidemiology
  • 国际环境流行病学学会
  • 方法、环境、职业和临床流行病学
  • 以严谨的方法学标准著称
Morbidity and Mortality Weekly Report (MMWR)
Emerging Infectious Diseases
The Lancet Infectious Diseases
  • 高影响力传染病期刊
  • 全球传染病威胁视角
  • 政策相关研究
International Journal of Epidemiology
  • 国际流行病学协会期刊
  • 方法、理论与实践
  • 全球卫生聚焦

Data Sources

数据源

Centers for Disease Control and Prevention (CDC)
World Health Organization (WHO)
  • Website: https://www.who.int/
  • Global disease surveillance (GISRS, GLASS)
  • Disease outbreak news
  • International Health Regulations (IHR) reporting
National Center for Health Statistics (NCHS)
  • Website: https://www.cdc.gov/nchs/
  • Vital statistics (births, deaths)
  • National Health Interview Survey
  • National Health and Nutrition Examination Survey
State and Local Health Departments
  • Reportable disease data
  • Outbreak investigations
  • Vital records
Global Burden of Disease (GBD) Study
美国疾病控制与预防中心（CDC）
世界卫生组织（WHO）
  • 网站：https://www.who.int/
  • 全球疾病监测（GISRS、GLASS）
  • 疾病暴发新闻
  • 国际卫生条例（IHR）报告
国家卫生统计中心（NCHS）
  • 网站：https://www.cdc.gov/nchs/
  • 生命统计（出生、死亡）
  • 全国健康访谈调查
  • 全国健康与营养检查调查
州和地方卫生部门
  • 法定报告疾病数据
  • 暴发调查
  • 生命记录
全球疾病负担（GBD）研究

Educational Resources

教育资源

CDC Principles of Epidemiology in Public Health Practice (Self-Study Course)
CDC Field Epidemiology Manual
Johns Hopkins Bloomberg School of Public Health OpenCourseWare
  • Free epidemiology courses and materials
  • Advanced methods and applications
Coursera Epidemiology Courses
  • University partnerships offering online epidemiology training
  • Johns Hopkins, Imperial College London, others
Council of State and Territorial Epidemiologists (CSTE) Resources
CDC公共卫生实践中的流行病学原则（自学课程）
CDC现场流行病学手册
约翰霍普金斯布隆伯格公共卫生学院OpenCourseWare
  • 免费流行病学课程和资料
  • 高级方法与应用
Coursera流行病学课程
  • 大学合作提供在线流行病学培训
  • 约翰霍普金斯、帝国理工学院等
州和地区流行病学家委员会（CSTE）资源

Key Textbooks and References

核心教材与参考资料

Modern Epidemiology (Rothman, Greenland, Lash)
  • Comprehensive methods textbook
  • Causal inference, study design, bias, confounding
Epidemiology: Beyond the Basics (Szklo, Nieto)
  • Intermediate-level textbook
  • Practical applications and interpretation
Infectious Disease Epidemiology: Theory and Practice (Nelson, Williams)
  • Comprehensive infectious disease epidemiology
  • Methods specific to infectious diseases
Outbreak Investigations Around the World: Case Studies in Infectious Disease Field Epidemiology (Greenfield, Rondy, Llanos-Cuentas)
  • Real-world case studies
  • Practical guidance for investigators
Modern Epidemiology（Rothman, Greenland, Lash）
  • 全面的方法学教材
  • 因果推断、研究设计、偏倚、混杂
Epidemiology: Beyond the Basics（Szklo, Nieto）
  • 中级教材
  • 实际应用与解读
Infectious Disease Epidemiology: Theory and Practice（Nelson, Williams）
  • 全面的传染病流行病学
  • 传染病特定方法
Outbreak Investigations Around the World: Case Studies in Infectious Disease Field Epidemiology（Greenfield, Rondy, Llanos-Cuentas）
  • 真实世界案例研究
  • 调查人员实用指南

Verification Checklist

验证清单

Disease Characterization: ☐ Clinical presentation and severity spectrum clearly described ☐ Incubation period and infectious period specified ☐ Transmission modes identified with evidence ☐ Case definition appropriate and standardized (clinical, laboratory, epidemiologic criteria)
Descriptive Epidemiology: ☐ Cases described by person, place, and time ☐ Epidemic curve constructed showing temporal pattern ☐ Attack rates calculated for relevant subgroups ☐ Geographic distribution mapped if relevant ☐ Outliers and unusual patterns investigated
Analytic Epidemiology: ☐ Appropriate study design selected (cohort, case-control, ecological) ☐ Exposure assessment thorough and unbiased ☐ Measures of association calculated (RR, OR, etc.) with confidence intervals ☐ Statistical significance assessed appropriately ☐ Confounding evaluated and addressed (stratification, multivariable adjustment) ☐ Effect modification assessed where relevant
Causal Inference: ☐ Bradford Hill criteria applied to assess causation ☐ Temporality established (exposure precedes disease) ☐ Biological plausibility considered ☐ Dose-response relationship evaluated if applicable ☐ Alternative explanations ruled out or addressed
Data Quality and Validity: ☐ Surveillance sensitivity and completeness assessed ☐ Selection bias considered and minimized ☐ Information bias (recall, measurement) evaluated ☐ Laboratory methods appropriate and quality-assured ☐ Sample size adequate for statistical power
Public Health Response: ☐ Control measures identified and implemented ☐ Target populations for intervention clearly specified ☐ Intervention effectiveness evaluated (before-after comparison) ☐ Unintended consequences considered ☐ Equity in intervention access assessed
Communication: ☐ Findings communicated to relevant stakeholders ☐ Recommendations specific, actionable, and evidence-based ☐ Uncertainty acknowledged where appropriate ☐ Limitations of study/analysis clearly stated
疾病表征： ☐ 临床表型和严重程度谱清晰描述 ☐ 潜伏期和传染期明确 ☐ 传播方式有证据支持 ☐ 病例定义适当且标准化（临床、实验室、流行病学标准）
描述性流行病学： ☐ 按人群、地点和时间描述病例 ☐ 构建流行曲线以显示时间模式 ☐ 计算相关亚组的罹患率 ☐ 绘制地理分布（如相关） ☐ 调查异常值和不寻常模式
分析性流行病学： ☐ 选择适当的研究设计（队列、病例对照、生态学） ☐ 暴露评估全面且无偏倚 ☐ 计算关联度量（RR、OR等）并给出置信区间 ☐ 适当评估统计显著性 ☐ 评估并解决混杂问题（分层、多变量调整） ☐ 评估相关的效应修饰
因果推断： ☐ 应用Bradford Hill criteria评估因果关系 ☐ 确立时序性（暴露先于疾病） ☐ 考虑生物学合理性 ☐ 评估剂量-反应关系（如适用） ☐ 排除或解决替代解释（混杂、偏倚）
数据质量与有效性： ☐ 评估监测敏感性和完整性 ☐ 考虑选择偏倚并最小化 ☐ 评估信息偏倚（回忆、测量） ☐ 实验室方法适当且经过质量保证 ☐ 样本量满足统计效力
公共卫生响应： ☐ 识别并实施控制措施 ☐ 明确干预的目标人群 ☐ 确定所需资源 ☐ 明确如何衡量有效性 ☐ 考虑潜在的意外后果
沟通： ☐ 向相关利益相关方沟通发现 ☐ 建议具体、可操作且循证 ☐ 适当承认不确定性 ☐ 明确说明研究/分析的局限性

Common Pitfalls

常见陷阱

Pitfall 1: Confusing Association with Causation

陷阱1：混淆关联与因果

Problem: Observing that two factors are associated and immediately concluding one causes the other, without considering alternative explanations like confounding or reverse causation.
Solution: Apply Bradford Hill criteria systematically. Consider temporality, strength, consistency, plausibility, dose-response. Design studies or use analytical methods to address confounding. Remember: association is necessary but not sufficient for causation.
问题：观察到两个因素相关，立即得出一个导致另一个的结论，未考虑混杂或反向因果等替代解释。
解决方案：系统应用Bradford Hill criteria。考虑时序性、强度、一致性、合理性、剂量-反应。设计研究或使用分析方法解决混杂。记住：关联是因果的必要非充分条件。

Pitfall 2: Ignoring Selection Bias

陷阱2：忽略选择偏倚

Problem: Cases or controls not representative of target population, leading to distorted associations. Common in case-control studies when controls don't represent population that gave rise to cases.
Solution: Carefully consider how cases and controls are selected. Ensure controls represent exposure distribution in source population. Use multiple control groups if needed. Assess whether selection factors are related to both exposure and outcome.
问题：病例或对照不能代表目标人群，导致关联扭曲。病例对照研究中常见对照不能代表产生病例的人群。
解决方案：仔细考虑病例和对照的选择方式。确保对照代表源人群的暴露分布。必要时使用多个对照组。评估选择因素是否与暴露和结局均相关。

Pitfall 3: Recall Bias in Retrospective Studies

陷阱3：回顾性研究中的回忆偏倚

Problem: Cases remember exposures differently than controls, particularly when disease is serious or exposure is stigmatized. Leads to artificial associations.
Solution: Use objective exposure data when possible (records, biomarkers). Standardize interviews and blind interviewers to case status. Collect exposure data before subjects know outcome (prospective designs). Validate self-reported exposures against records.
问题：病例对暴露的记忆与对照不同，尤其当疾病严重或暴露有污名时。导致人为关联。
解决方案：尽可能使用客观暴露数据（记录、生物标志物）。标准化访谈并使访谈者对病例状态盲法。在受试者知道结局前收集暴露数据（前瞻性设计）。验证自我报告暴露与记录的一致性。

Pitfall 4: Misinterpreting Epidemic Curves

陷阱4：误读流行曲线

Problem: Failing to recognize outbreak pattern (point-source vs. propagated), working backward incorrectly to identify exposure time, or missing secondary waves.
Solution: Understand incubation periods and generation times. Point-source outbreaks have sharp peaks within one incubation period. Propagated outbreaks show successive peaks. Work backward from peak by median incubation period to estimate exposure time. Look for outliers suggesting index cases.
问题：未能识别暴发模式（点源 vs 传播性），倒推暴露时间错误，或遗漏二代波。
解决方案：理解潜伏期和代时。点源暴发在一个潜伏期内出现尖锐峰值。传播性暴发显示连续峰值。从峰值按中位潜伏期倒推以估算暴露时间。寻找提示指示病例的异常值。

Pitfall 5: Inadequate Sample Size

陷阱5：样本量不足

Problem: Studies too small to detect true associations, leading to false negative findings. Particularly common in outbreak investigations with limited cases.
Solution: Calculate required sample size in advance when possible. For small outbreaks, recognize limitations and interpret null findings cautiously. Consider combining data across outbreaks. Use exact statistical methods appropriate for small samples. Report confidence intervals, not just p-values.
问题：研究规模过小无法检测真实关联，导致假阴性结果。在病例有限的暴发调查中尤其常见。
解决方案：尽可能提前计算所需样本量。对于小型暴发，认识到局限性并谨慎解读阴性结果。考虑合并多个暴发的数据。使用适用于小样本的精确统计方法。报告置信区间，而非仅P值。

Pitfall 6: Failing to Validate Surveillance Data

陷阱6：未验证监测数据

Problem: Assuming reported cases represent true disease occurrence without considering surveillance system sensitivity, specificity, and completeness. Leads to incorrect burden estimates.
Solution: Evaluate surveillance system attributes (sensitivity, PPV, timeliness, representativeness). Conduct capture-recapture studies to estimate underreporting. Validate diagnoses through record review. Consider reporting biases and changes in case definitions or testing practices over time.
问题：假设报告病例代表真实疾病发生，未考虑监测系统的敏感性、特异性和完整性。导致错误的负担估算。
解决方案：评估监测系统属性（敏感性、PPV、及时性、代表性）。开展捕获-再捕获研究估算漏报。通过记录回顾验证诊断。考虑报告偏倚和病例定义或检测实践随时间的变化。

Pitfall 7: Neglecting Time Trends and Lag Periods

陷阱7：忽略时间趋势和滞后周期

Problem: Analyzing cross-sectional relationships without considering temporal dynamics, latency periods between exposure and disease, or time-varying confounders.
Solution: Always consider time. For chronic diseases, look back to relevant exposure windows. For infectious diseases, account for incubation periods. Use time series methods when appropriate. Consider lag times in intervention effects.
问题：分析横断面关系时未考虑时间动态、暴露与疾病之间的潜伏期或时变混杂。
解决方案：始终考虑时间。对于慢性病，回顾相关暴露窗口。对于传染病，考虑潜伏期。必要时使用时间序列方法。考虑干预效应的滞后时间。

Pitfall 8: Overlooking Ethical Considerations

陷阱8：忽视伦理考量

Problem: Conducting investigations or interventions without considering ethical implications, particularly for vulnerable populations. Violating privacy or failing to obtain appropriate consent.
Solution: Follow established ethical guidelines (Belmont Report principles). Obtain IRB approval for research. Protect confidentiality. Ensure informed consent when appropriate. Balance individual rights with public health needs. Consider justice and equitable distribution of benefits/risks.
问题：开展调查或干预时未考虑伦理影响，尤其针对脆弱人群。侵犯隐私或未获得适当同意。
解决方案：遵循既定伦理指南（贝尔蒙报告原则）。研究获得IRB批准。保护隐私。必要时获得知情同意。平衡个人权利与公共卫生需求。考虑公平和利益/风险的公平分配。

Success Criteria

成功标准

Comprehensive Disease Understanding: ☐ Disease characteristics fully described (transmission, incubation, severity) ☐ Natural history and clinical spectrum understood ☐ Population most at risk clearly identified ☐ Temporal and geographic patterns characterized
Rigorous Methodology: ☐ Appropriate study design selected and justified ☐ Case definition standardized and appropriate ☐ Sampling strategy minimizes selection bias ☐ Exposure assessment valid and reliable ☐ Sample size adequate or limitations acknowledged ☐ Statistical methods appropriate for data type and structure
Valid Causal Inference: ☐ Bradford Hill criteria applied to assess causation ☐ Confounding addressed through design or analysis ☐ Effect modification explored where relevant ☐ Biological plausibility considered ☐ Alternative explanations evaluated and ruled out ☐ Temporality established (exposure precedes outcome)
Quantitative Precision: ☐ Appropriate measures calculated (rates, risks, ORs, RRs) ☐ Confidence intervals reported for point estimates ☐ Stratified analyses conducted for key subgroups ☐ Dose-response relationships assessed when applicable
Actionable Public Health Insights: ☐ Specific risk factors identified with evidence ☐ Control measures recommended based on findings ☐ Target populations for intervention specified ☐ Prevention strategies evidence-based and feasible ☐ Intervention effectiveness evaluated or planned
Health Equity Considerations: ☐ Disease burden disparities identified and quantified ☐ Differential exposures or vulnerabilities explained ☐ Barriers to prevention/care assessed ☐ Interventions designed to reduce inequities ☐ Equitable access to interventions ensured
Effective Communication: ☐ Findings clearly communicated to stakeholders ☐ Technical content translated for non-technical audiences ☐ Recommendations specific, actionable, prioritized ☐ Uncertainty and limitations transparently stated ☐ Scientific findings disseminated through appropriate channels
Timely Action: ☐ Outbreak investigations initiated promptly ☐ Preliminary findings communicated early for rapid control ☐ Control measures implemented without waiting for perfect data ☐ Iterative investigation refines understanding as new data emerges
全面的疾病理解： ☐ 疾病特征充分描述（传播、潜伏期、严重程度） ☐ 理解自然史和临床谱 ☐ 明确最易受影响的人群 ☐ 表征时间和地理模式
严谨的方法学： ☐ 选择并论证适当的研究设计 ☐ 病例定义标准化且适当 ☐ 抽样策略最小化选择偏倚 ☐ 暴露评估有效且可靠 ☐ 样本量充足或局限性被承认 ☐ 统计方法适合数据类型和结构
有效的因果推断： ☐ 应用Bradford Hill criteria评估因果关系 ☐ 通过设计或分析解决混杂 ☐ 探索相关的效应修饰 ☐ 考虑生物学合理性 ☐ 评估并排除替代解释 ☐ 确立时序性（暴露先于结局）
定量精准性： ☐ 计算适当的度量（率、风险、OR、RR） ☐ 报告点估计的置信区间 ☐ 对关键亚组开展分层分析 ☐ 评估适用的剂量-反应关系
可操作的公共卫生洞见： ☐ 识别有证据支持的特定风险因素 ☐ 根据发现建议控制措施 ☐ 明确干预的目标人群 ☐ 循证且可行的预防策略 ☐ 评估或规划干预措施有效性
健康公平性考量： ☐ 识别并量化疾病负担差异 ☐ 解释差异暴露或脆弱性 ☐ 评估预防/医疗服务的障碍 ☐ 设计干预措施以减少不公平 ☐ 确保干预措施的公平可及性
有效的沟通： ☐ 向利益相关方清晰沟通发现 ☐ 技术内容转化为非技术受众可理解的语言 ☐ 建议具体、可操作且优先排序 ☐ 透明说明不确定性和局限性 ☐ 通过适当渠道传播科学发现
及时行动： ☐ 及时启动暴发调查 ☐ 早期沟通初步发现以快速控制 ☐ 无需完美数据即可实施控制措施 ☐ 迭代调查随着新数据出现细化理解

Integration with Other Analysts

与其他分析师的整合

Epidemiologist analysis complements and integrates with other domain experts:
With Historian: Epidemiology benefits from historical context of past epidemics, evolution of disease patterns, and lessons from previous outbreaks. Historians provide long-term perspective on disease emergence and control efforts.
With Political Scientist: Public health policy implementation depends on political will, governance structures, and power dynamics. Political scientists explain policy adoption, resource allocation, and institutional responses.
With Economist: Economic analysis informs cost-effectiveness of interventions, health care financing, incentive structures affecting health behaviors, and economic impacts of disease and control measures.
With Sociologist: Social determinants of health, health disparities, cultural factors affecting health behaviors, and community structures influencing disease transmission all require sociological insight.
With Psychologist: Health behavior change, risk perception, vaccine hesitancy, mental health impacts of outbreaks, and trauma-informed care integrate psychological understanding.
With Ethicist: Ethical frameworks guide decisions on quarantine, isolation, resource allocation, research conduct, and balancing individual liberty with collective protection.
With Biologist: Pathogen biology, host-pathogen interactions, antimicrobial resistance, vector ecology, and zoonotic spillover require biological expertise.
What Epidemiologist Brings:
  • Quantitative methods for measuring disease occurrence and associations
  • Frameworks for establishing causation from observational data
  • Systematic outbreak investigation methodology
  • Population-level perspective (not just individual risk)
  • Evidence synthesis for public health decision-making
  • Intervention evaluation rigor
流行病学分析补充并整合其他领域专家：
与历史学家：流行病学受益于过去流行病的历史背景、疾病模式的演变和既往暴发的教训。历史学家提供疾病出现和控制措施的长期视角。
与政治学家：公共卫生政策实施取决于政治意愿、治理结构和权力动态。政治学家解释政策采纳、资源分配和机构响应。
与经济学家：经济分析为干预措施的成本效益、医疗融资、影响健康行为的激励结构以及疾病和控制措施的经济影响提供信息。
与社会学家：健康的社会决定因素、健康差异、影响健康行为的文化因素以及影响疾病传播的社区结构均需要社会学洞见。
与心理学家：健康行为改变、风险感知、疫苗犹豫、暴发对心理健康的影响以及创伤知情护理均整合心理学理解。
与伦理学家：伦理框架指导隔离、检疫、资源分配、研究行为以及个人自由与集体保护平衡的决策。
与生物学家：病原体生物学、宿主-病原体相互作用、抗菌药物耐药性、媒介生态学和人畜共患病 spillover 需要生物学专业知识。
流行病学家的贡献：
  • 测量疾病发生和关联的定量方法
  • 从观察数据确立因果关系的框架
  • 系统的暴发调查方法学
  • 人群层面视角（不仅个体风险）
  • 公共卫生决策的证据合成
  • 干预措施评估的严谨性

Continuous Improvement

持续改进

This skill evolves as epidemiological methods advance and new health threats emerge. Document new frameworks, update with recent outbreaks, incorporate emerging technologies (genomic epidemiology, wastewater surveillance, AI-enhanced forecasting), and refine based on practical application and feedback from field investigations. Epidemiology is both science and practice—continuous learning from real-world investigations strengthens both.
随着流行病学方法的进步和新健康威胁的出现，本技能不断演进。记录新框架、更新近期暴发、整合新兴技术（基因组流行病学、污水监测、AI增强预测），并根据实地调查的实际应用和反馈进行改进。流行病学既是科学也是实践——从真实世界调查中持续学习可强化两者。